Code	CDISC Codelist	CDISC Value	NCI Preferred Term	CDISC Definition	CDISC Synonym(s) (where applicable)
C49499	Action Taken with Study Treatment 	[ACN]		The reason that changes were made to the therapy under study. (NCI)	Action Taken with Study Treatment
C49503	Action Taken with Study Treatment 	DOSE INCREASED	Dose Increased	An indication that a medication schedule was modified by addition; either by changing the frequency, strength or amount. (NCI)	
C49504	Action Taken with Study Treatment 	DOSE NOT CHANGED	Dose Not Changed	An indication that a medication schedule was maintained. (NCI)	
C49505	Action Taken with Study Treatment 	DOSE REDUCED	Dose Reduced	An indication that a medication schedule was modified by subtraction, either by changing the frequency, strength or amount. (NCI)	
C49501	Action Taken with Study Treatment 	DRUG INTERRUPTED	Drug Interrupted	An indication that a medication schedule was modified by temporarily terminating a prescribed regimen of medication. (NCI)	
C49502	Action Taken with Study Treatment 	DRUG WITHDRAWN	Drug Withdrawn	An indication that a medication schedule was modified through termination of a prescribed regimen of medication. (NCI)	
C48660	Action Taken with Study Treatment 	NA	Not Applicable	Determination of a value is not relevant in the current context. (NCI)	NOT APPLICABLE
C17998	Action Taken with Study Treatment 	U	Unknown	Not known, not observed, not recorded, or refused. (NCI)	UNKNOWN
C49489	Adverse Event Outcome	[OUT]		A condition or event that is attributed to the adverse event and is the result or conclusion of the adverse event. (NCI)	Outcome of Event
C48275	Adverse Event Outcome	5	Death Related to Adverse Event	The termination of life as a result of an adverse event. (NCI)	FATAL; Grade 5
C49494	Adverse Event Outcome	NOT RECOVERED/NOT RESOLVED	Not Recovered or Not Resolved	One of the possible results of an adverse event outcome that indicates that the event has not improved or recuperated. (NCI)	
C49498	Adverse Event Outcome	RECOVERED/RESOLVED	Recovered or Resolved	One of the possible results of an adverse event outcome that indicates that the event has improved or recuperated. (NCI)	
C49495	Adverse Event Outcome	RECOVERED/RESOLVED WITH SEQUELAE	Recovered or Resolved with Sequelae	One of the possible results of an adverse event outcome where the subject recuperated but retained pathological conditions resulting from the prior disease or injury. (NCI)	
C49496	Adverse Event Outcome	RECOVERING/RESOLVING	Recovering or Resolving	One of the possible results of an adverse event outcome that indicates that the event is improving. (NCI)	
C17998	Adverse Event Outcome	U	Unknown	Not known, not observed, not recorded, or refused. (NCI)	UNKNOWN
C20587	Age Group	[AGESPAN]		Subgroups of populations based on age. (NCI)	Age Span
C27954	Age Group	ADOLESCENT (12-17 YEARS)	Adolescent	A juvenile between the onset of puberty and maturity; in the state of development between puberty and maturity. (NCI)	
C49685	Age Group	ADULT (18-65)	Adult 18-65 Years Old	A person from 18 years to 65 years of age. (NCI)	
C49683	Age Group	CHILDREN (2-11 YEARS)	Children 2-11 Years Old	A person from 2 years to 11 years of age. (NCI)	
C16268	Age Group	ELDERLY (> 65)	Elderly	An age group comprised by people 65 years of age and older. (NCI) 	
C49641	Age Group	IN UTERO	In Utero	The period of time during which the embryo or foetus is present in the uterus of the female. Also describes the location of the embryo or foetus as being in the uterus in contrast to outside the uterus (ex utero). (NCI)	
C49643	Age Group	INFANT AND TODDLER (28 DAYS - 23 MONTHS)	Infant And Toddler	A person from 28 days to 23 months of age. (NCI)	
C16731	Age Group	NEWBORN (0-27 DAYS)	Newborn	An infant during the first month after birth. (NCI)	
C49642	Age Group	PRETERM NEWBORN INFANTS	Preterm Newborn Infant	An infant born prior to completion of the normal gestation period. (NCI)	
C50400	Age Unit	[AGEU]		Those units of time that are routinely used to express the age of a person. (NCI)	Age Units
C25301	Age Unit	DAYS	Day	The time for Earth to make a complete rotation on its axis; ordinarily divided into twenty-four hours.  This also refers to a specific day. (NCI)	
C25529	Age Unit	HOURS	Hour	A unit measure of time equal to 3,600 seconds or 60 minutes. It is approximately 1/24 of a median day. (NCI)	
C29846	Age Unit	MONTHS	Month	One of the 12 divisions of a year as determined by a calendar.  It corresponds to the unit of time of approximately to one cycle of the moon's phases, about 30 days or 4 weeks. (NCI)	
C29844	Age Unit	WEEKS	Week	Any period of seven consecutive days. (NCI)	
C29848	Age Unit	YEARS	Year	The period of time that it takes for Earth to make a complete revolution around the sun, approximately 365 days; a specific one year period. (NCI)	
C49480	Category for Inclusion and or Exclusion	[IECAT]		A collection of criteria on which subjects are evaluated and that must be met by all study subjects. (NCI)	Category for Inclusion/Exclusion
C25370	Category for Inclusion and or Exclusion	EXCLUSION	Exclusion	List of characteristics in a protocol, any one of which may exclude a potential subject from participation in a study. (CDISC glossary)	
C25532	Category for Inclusion and or Exclusion	INCLUSION	Inclusion	The criteria in a protocol that prospective subjects must meet to be eligible for participation in a study.  NOTE: Exclusion and inclusion criteria define the study population. See also exclusion criteria. (CDISC glossary)	
C64388	CDISC System Organ Class	[SOC]		Terms at the highest level of the CDISC system organ class terminology.	System Organ Class
C35814	CDISC System Organ Class	BLOOD AND LYMPHATIC SYSTEM DISORDERS	Hematopoietic and Lymphoid System Disorder	Any deviation from the normal structure or function of the blood or lymphatic system that is manifested by a characteristic set of symptoms and signs. (NCI)	
C3079	CDISC System Organ Class	CARDIAC DISORDERS	Heart Disorder	Any deviation from the normal structure or function of the cardiac system that is manifested by a characteristic set of symptoms and signs. (NCI)	
C49399	CDISC System Organ Class	CONGENITAL, FAMILIAL AND GENETIC DISORDERS	Congenital, Familial and Genetic Disorder Class	A class of disorders that encompasses conditions resulting from a congenital, familial hereditary trait or genetic abnormality as is manifested by a characterstic set of symptoms and signs. (NCI)	
C49400	CDISC System Organ Class	EAR AND LABYRINTH DISORDERS	Ear and Labyrinth Disorder Class	Any deviation from the normal structure or function of the ear or labyrinth that is manifested by a characteristic set of symptoms and signs. (NCI)	
C3009	CDISC System Organ Class	ENDOCRINE DISORDERS	Endocrine Disorder	Any deviation from the normal structure or function of the endocrine system that is manifested by a characteristic set of symptoms and signs. (NCI)	
C26767	CDISC System Organ Class	EYE DISORDERS	Eye Disorder	Any deviation from the normal structure or function of the eye that is manifested by a characteristic set of symptoms and signs. (NCI)	
C2990	CDISC System Organ Class	GASTROINTESTINAL DISORDERS	Gastrointestinal Disorder	Diseases of the digestive tract (oral cavity to anus) and associated organs (salivary glands, liver, pancreas). (NCI)	
C49401	CDISC System Organ Class	GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS	General Disorders and Administration Site Conditions Class	A class of disorders that encompasses conditions of a general kind that result from a disease, the treatment of disease or administration of treatment at a particular site and are manifested by a characteristic set of symptoms and signs. (NCI)	
C3959	CDISC System Organ Class	HEPATOBILIARY DISORDERS	Liver and Biliary Tract Disorder	Any deviation from the normal structure or function of the liver or biliary tract that is manifested by a characteristic set of symptoms and signs. (NCI)	
C3507	CDISC System Organ Class	IMMUNE SYSTEM DISORDERS	Immune System Disorder	A disorder resulting from an abnormality in the immune system. -- 2003 (NCI)	
C26726	CDISC System Organ Class	INFECTIONS AND INFESTATIONS	Infectious Disorder	A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact. -- 2003 (NCI)	
C49402	CDISC System Organ Class	INJURY, POISONING AND PROCEDURAL COMPLICATIONS	Injury, Poisoning and Procedural Complication Class	A class of disorders that encompasses conditions resulting from an injury, poisoning or procedure. (NCI)	
C41198	CDISC System Organ Class	INVESTIGATIONS	Investigation	The act or process of a systematic and thorough examination; research, study; the process of inquiring into or following up, intended to develop facts. (NCI)	
C49403	CDISC System Organ Class	METABOLISM AND NUTRITION DISORDERS	Metabolism and Nutrition Disorder Class	A class of disorders that encompasses conditions occurring as a result of metabolic dysfunction or deviation from the normal nutritional requirements. (NCI)	
C27574	CDISC System Organ Class	MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS	Connective and Soft Tissue Disorder	Any deviation from the normal structure or function of the musculoskeletal or connective tissue that is manifested by a characteristic set of symptoms and signs. (NCI)	
C3262	CDISC System Organ Class	NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYSTS AND POLYPS)	Neoplasm	An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)	
C26835	CDISC System Organ Class	NERVOUS SYSTEM DISORDERS	Nervous System Disorder	Any deviation from the normal structure or function of the nervous system that is manifested by a characteristic set of symptoms and signs. (NCI)	
C49404	CDISC System Organ Class	PREGNANCY, PUERPERIUM AND PERINATAL CONDITIONS	Pregnancy, Puerperium and Perinatal Condition Class	A class of conditions associated with pregnancy, puerperium and perinatal status. (NCI)	
C2893	CDISC System Organ Class	PSYCHIATRIC DISORDERS	Psychiatric Disorder	Any deviation from the normal structure or function of the brain and a psychiatric condition, that results in an impairment of an individual's normal cognitive, emotional, or behavioral functioning, and is caused by physiological or psychosocial factors. (NCI)	
C3430	CDISC System Organ Class	RENAL AND URINARY DISORDERS	Urinary System Disorder	Disorders of any part of the urologic system. (NCI)	
C49405	CDISC System Organ Class	REPRODUCTIVE SYSTEM AND BREAST DISORDERS	Reproductive System and Breast Disorder Class	Any deviation from the normal structure or function of the reproductive system or breast that is manifested by a characteristic set of symptoms and signs. (NCI)	
C27669	CDISC System Organ Class	RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS	Respiratory and Thoracic Disorder	Any deviation from the normal structure or function of the respiratory system including the thorax and mediastinum that is manifested by a characteristic set of symptoms and signs. (NCI)	
C3371	CDISC System Organ Class	SKIN AND SUBCUTANEOUS TISSUE DISORDERS	Skin Disorder	Any deviation from the normal structure or function of the skin or subcutaneous tissue that is manifested by a characteristic set of symptoms and signs.(NCI)	
C20188	CDISC System Organ Class	SOCIAL CIRCUMSTANCES	Social Circumstances	A set of concepts that results from or is influenced by criteria or activities associated with the social environment of a person. (NCI)	
C25218	CDISC System Organ Class	SURGICAL AND MEDICAL PROCEDURES	Procedure	A particular course of action intended to achieve a result. (NCI)	
C35117	CDISC System Organ Class	VASCULAR DISORDERS	Vascular Disorder	Any deviation from the normal structure or function of the vascular system that is manifested by a characteristic set of symptoms and signs. (NCI)	
C49704	Common Terminology Criteria for Adverse Events	[TOXGR]		A standard terminology developed to report adverse events occurring in cancer clinical trials.  Common terminology criteria for adverse events (CTCAE) are used in study adverse event summaries and Investigational New Drug reports to the Food and Drug Administration.  The CTCAE contain a grading scale for each adverse event term representing the severity of the event. (NCI)	Standard Toxicity Grade
C41338	Common Terminology Criteria for Adverse Events	1	Mild Adverse Event	A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.	Grade 1; MILD
C41339	Common Terminology Criteria for Adverse Events	2	Moderate Adverse Event	A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.	Grade 2; MODERATE
C41340	Common Terminology Criteria for Adverse Events	3	Severe Adverse Event	A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.	Grade 3; SEVERE
C41337	Common Terminology Criteria for Adverse Events	4	Life Threatening or Disabling Adverse Event	An adverse event, and/or its immediate sequelae, which is associated with an imminent risk of death or which is associated with physical or mental disabilities that affect or limit the ability of a person to perform activities of daily living (eating, ambulation, toileting, etc.) See NCI Common Terminology Criteria for Adverse Events.	Grade 4; 
C48275	Common Terminology Criteria for Adverse Events	5	Death Related to Adverse Event	The termination of life as a result of an adverse event. (NCI)	FATAL; Grade 5
C49647	Control Type	[TCNTRL]		Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).	Type of Control
C49649	Control Type	ACTIVE	Active Control	A type of control, which has a demonstrated effect, administered as a comparator, to subjects in a clinical trial. [From ICH E10].	
C41132	Control Type	NONE	None	No person or thing, nobody, not any. (NCI)	
C49648	Control Type	PLACEBO	Placebo Control	Use of an inactive compound identical in appearance to drug or treatment being tested in experimental research, which may or may not be known to the physician and/or subject, administered to distinguish between drug action and suggestive effect of the drug or treatment under study. The effects of the active drug or treatment are compared to the effects of the placebo. (NCI)	
C25464	Country	[COUNTRY]		A collective generic term that refers here to a wide variety of dependencies, areas of special sovereignty, uninhabited islands, and other entities in addition to the traditional countries or independent states. (NCI)	Country
C17884	Country	ABW	Aruba	Island in the Caribbean Sea, north of Venezuela.	ARUBA
C16267	Country	AFG	Afghanistan	A country in Southern Asia, north and west of Pakistan, east of Iran.	AFGHANISTAN
C16292	Country	AGO	Angola	A country in Southern Africa, bordering the South Atlantic Ocean, between Namibia and Democratic Republic of the Congo.	ANGOLA
C20133	Country	AIA	Anguilla	An island in the Caribbean Sea, east of Puerto Rico.	ANGUILLA
C44481	Country	ALA	Aland Islands	An archipelago in the Baltic Sea at the entrance to the Gulf of Bothnia between Sweden and Finland.	ALAND ISLANDS
C16271	Country	ALB	Albania	A country in Southeastern Europe, bordering the Adriatic Sea and Ionian Sea, between Greece and Serbia and Montenegro.	ALBANIA
C16289	Country	AND	Andorra	A country in Southwestern Europe, between France and Spain.	ANDORRA
C16904	Country	ANT	Netherlands Antilles	A country in the Caribbean, comprising two island groups in the Caribbean Sea - one includes Curacao and Bonaire north of Venezuela; the other is east of the Virgin Islands.	NETHERLANDS ANTILLES
C17232	Country	ARE	United Arab Emirates	A country in the Middle East, bordering the Gulf of Oman and the Persian Gulf, between Oman and Saudi Arabia.	UNITED ARAB EMIRATES
C16305	Country	ARG	Argentina	A country in Southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.	ARGENTINA
C16306	Country	ARM	Armenia	A country in Southwestern Asia, east of Turkey.	ARMENIA
C17739	Country	ASM	American Samoa	A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand.	AMERICAN SAMOA
C18007	Country	ATA	Antarctica	The continent lying mostly south of the Antarctic Circle.	ANTARCTICA
C20105	Country	ATF	French Southern Territories	Islands in the southern Indian Ocean, south of Africa, about equidistant between Africa, Antarctica, and Australia.	FRENCH SOUTHERN TERRITORIES
C16303	Country	ATG	Antigua and Barbuda	Islands between the Caribbean Sea and the North Atlantic Ocean, east-southeast of Puerto Rico.	ANTIGUA AND BARBUDA
C16311	Country	AUS	Australia	The continent between the Indian Ocean and the South Pacific Ocean.	AUSTRALIA
C16312	Country	AUT	Austria	A country in Central Europe, north of Italy and Slovenia.	AUSTRIA
C16316	Country	AZE	Azerbaijan	A country in Southwestern Asia, bordering the Caspian Sea, between Iran and Russia.	AZERBAIJAN
C16371	Country	BDI	Burundi	A country in Central Africa, east of Democratic Republic of the Congo.	BURUNDI
C16329	Country	BEL	Belgium	A country in Western Europe, bordering the North Sea, between France and the Netherlands.	BELGIUM
C16333	Country	BEN	Benin Republic	A country in Western Africa, bordering the North Atlantic Ocean, between Nigeria and Togo.	BENIN REPUBLIC
C16369	Country	BFA	Burkina Faso	A country in Western Africa, north of Ghana.	BURKINA FASO
C16323	Country	BGD	Bangladesh	A country in Southern Asia, bordering the Bay of Bengal, between Burma and India.	BANGLADESH
C16368	Country	BGR	Bulgaria	A country in Southeastern Europe, bordering the Black Sea, between Romania and Turkey.	BULGARIA
C16322	Country	BHR	Bahrain	An archipelago in the Persian Gulf, east of Saudi Arabia.	BAHRAIN
C16321	Country	BHS	Bahamas	A chain of islands in the North Atlantic Ocean, southeast of Florida.	BAHAMAS
C16361	Country	BIH	Bosnia-Herzegovina	A country in Southeastern Europe, bordering the Adriatic Sea and Croatia.	BOSNIA-HERZEGOVINA
C16372	Country	BLR	Belarus	A country in Eastern Europe, east of Poland.	BELARUS
C16331	Country	BLZ	Belize	A country in Central America, bordering the Caribbean Sea, between Guatemala and Mexico.	BELIZE
C16334	Country	BMU	Bermuda	No Definition	BERMUDA
C16359	Country	BOL	Bolivia	A country in Central South America, southwest of Brazil.	BOLIVIA
C16364	Country	BRA	Brazil	A country in Eastern South America, bordering the Atlantic Ocean.	BRAZIL
C16324	Country	BRB	Barbados	An island between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.	BARBADOS
C16367	Country	BRN	Brunei Darussalam	A country in Southeastern Asia, bordering the South China Sea and Malaysia.	BRUNEI
C16336	Country	BTN	Bhutan	A country in Southern Asia, between China and India.	BHUTAN
C20104	Country	BVT	Bouvet Island	An island in the South Atlantic Ocean, south-southwest of the Cape of Good Hope (South Africa).	BOUVET ISLAND
C16363	Country	BWA	Botswana	A country in Southern Africa, north of South Africa.	BOTSWANA
C16409	Country	CAF	Central African Republic	A country in Central Africa, north of Democratic Republic of the Congo.	CENTRAL AFRICAN REPUBLIC
C16380	Country	CAN	Canada	A country in Northern North America, bordering the North Atlantic Ocean on the east, North Pacific Ocean on the west, and the Arctic Ocean on the north, north of the conterminous US.	CANADA
C16445	Country	CCK	Cocos (Keeling) Islands	A group of islands in the Indian Ocean, south of Indonesia, about halfway from Australia to Sri Lanka.	COCOS (KEELING) ISLANDS
C17181	Country	CHE	Switzerland	A country in Central Europe, east of France, north of Italy.	SWITZERLAND
C16427	Country	CHL	Chile	A country in Southern South America, bordering the South Atlantic Ocean and South Pacific Ocean, between Argentina and Peru.	CHILE
C16428	Country	CHN	China	A country in Eastern Asia, bordering the East China Sea, Korea Bay, Yellow Sea, and South China Sea, between North Korea and Vietnam.	CHINA
C16762	Country	CIV	Cote d'Ivoire	A country in Western Africa, bordering the North Atlantic Ocean, between Ghana and Liberia.	COTE D'IVOIRE
C16379	Country	CMR	Cameroon	A country in Western Africa, bordering the Bight of Biafra, between Equatorial Guinea and Nigeria.	CAMEROON
C17266	Country	COD	Democratic Republic of the Congo	A country in Central Africa, northeast of Angola.	DEMOCRATIC REPUBLIC OF THE CONGO
C16467	Country	COG	Congo	A country in Western Africa, bordering the South Atlantic Ocean, between Angola and Gabon.	CONGO
C16469	Country	COK	Cook Islands	A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.	COOK ISLANDS
C16449	Country	COL	Colombia	A country in Northern South America, bordering the Caribbean Sea, between Panama and Venezuela, and bordering the North Pacific Ocean, between Ecuador and Panama.	COLOMBIA
C16458	Country	COM	Comoros	A group of islands in the Mozambique Channel, about two-thirds of the way between northern Madagascar and northern Mozambique.	COMOROS
C16382	Country	CPV	Cape Verde	A group of islands in the North Atlantic Ocean, west of Senegal.	CAPE VERDE
C16470	Country	CRI	Costa Rica	A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Nicaragua and Panama.	COSTA RICA
C16477	Country	CUB	Cuba	An island between the Caribbean Sea and the North Atlantic Ocean, 150 km south of Key West, Florida.	CUBA
C44482	Country	CXR	Christmas Island	An Australian-administered island in the eastern Indian Ocean south of Java, Indonesia.	CHRISTMAS ISLAND
C16391	Country	CYM	Cayman Islands	An island group in the Caribbean Sea, nearly one-half of the way from Cuba to Honduras.	CAYMAN ISLANDS
C16480	Country	CYP	Cyprus	An island in the Mediterranean Sea, south of Turkey.	CYPRUS
C17668	Country	CZE	Czech Republic	A country in Central Europe, southeast of Germany.	CZECH REPUBLIC
C16636	Country	DEU	Germany	A country in Central Europe, bordering the Baltic Sea and the North Sea, between the Netherlands and Poland, south of Denmark.	GERMANY
C16506	Country	DJI	Djibouti	A country in Eastern Africa, bordering the Gulf of Aden and the Red Sea, between Eritrea and Somalia.	DJIBOUTI
C16519	Country	DMA	Dominica	An island between the Caribbean Sea and the North Atlantic Ocean, about one-half of the way from Puerto Rico to Trinidad and Tobago.	DOMINICA
C16496	Country	DNK	Denmark	A country in Northern Europe, bordering the Baltic Sea and the North Sea, on a peninsula north of Germany (Jutland); also includes two major islands (Sjaelland and Fyn).	DENMARK
C16520	Country	DOM	Dominican Republic	A country comprising the eastern two-thirds of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, east of Haiti.	DOMINICAN REPUBLIC
C16274	Country	DZA	Algeria	A country in Northern Africa, bordering the Mediterranean Sea, between Morocco and Tunisia.	ALGERIA
C16528	Country	ECU	Ecuador	A country in Western South America, bordering the Pacific Ocean at the Equator, between Colombia and Peru.	ECUADOR
C16530	Country	EGY	Egypt	A country in Northern Africa, bordering the Mediterranean Sea, between Libya and the Gaza Strip.	EGYPT
C16558	Country	ERI	Eritrea	A country in Eastern Africa, bordering the Red Sea, between Djibouti and Sudan.	ERITREA
C20113	Country	ESH	Western Sahara	A country in Northern Africa, bordering the North Atlantic Ocean, between Mauritania and Morocco.	WESTERN SAHARA
C17152	Country	ESP	Spain	A country in Southwestern Europe, bordering the Bay of Biscay, Mediterranean Sea, North Atlantic Ocean, and Pyrenees Mountains, southwest of France.	SPAIN
C16562	Country	EST	Estonia	A country in Eastern Europe, bordering the Baltic Sea and Gulf of Finland, between Latvia and Russia.	ESTONIA
C16563	Country	ETH	Ethiopia	A country in Eastern Africa, west of Somalia.	ETHIOPIA
C16584	Country	FIN	Finland	A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia.	FINLAND
C16582	Country	FJI	Fiji	An island group in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.	FIJI
C17954	Country	FLK	Falkland Islands	Islands in the South Atlantic Ocean, east of southern Argentina.	FALKLAND ISLANDS
C16592	Country	FRA	France	A country in Western Europe, bordering the Bay of Biscay and English Channel, between Belgium and Spain, southeast of the UK; bordering the Mediterranean Sea, between Italy and Spain.	FRANCE
C16573	Country	FRO	Faroe Islands	An island group between the Norwegian Sea and the North Atlantic Ocean, about one-half of the way from Iceland to Norway.	FAROE ISLANDS
C17881	Country	FSM	Federated States of Micronesia	An island group in the North Pacific Ocean, about three-quarters of the way from Hawaii to Indonesia.	MICRONESIA, FEDERATED STATES OF
C16596	Country	GAB	Gabon	A country in Western Africa, bordering the Atlantic Ocean at the Equator, between Republic of the Congo and Equatorial Guinea.	GABON
C17233	Country	GBR	United Kingdom	A country in Western Europe, comprising islands, including the northern one-sixth of the island of Ireland, between the North Atlantic Ocean and the North Sea, northwest of France.	UNITED KINGDOM
C16634	Country	GEO	Georgia	A country in Southwestern Asia, bordering the Black Sea, between Turkey and Russia.	GEORGIA
C64375	Country	GGY	Guernsey	The island of Guernsey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy, which held sway in both France and England. Guernsey is a British crown dependency, but is not part of the UK.	GUERNSEY
C26330	Country	GHA	Ghana	A country in Western Africa, bordering the Gulf of Guinea, between Cote d'Ivoire and Togo.	GHANA
C16638	Country	GIB	Gibraltar	A dependency in Southwestern Europe, bordering the Strait of Gibraltar, on the southern coast of Spain.	GIBRALTAR
C16655	Country	GIN	Guinea	A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Sierra Leone.	GUINEA
C16651	Country	GLP	Guadeloupe	Islands in the eastern Caribbean Sea, southeast of Puerto Rico.	GUADELOUPE
C16598	Country	GMB	Gambia	A country in Western Africa, bordering the North Atlantic Ocean and Senegal.	GAMBIA
C16656	Country	GNB	Guinea-Bissau	A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Senegal.	GUINEA-BISSAU
C16557	Country	GNQ	Equatorial Guinea	A country in Western Africa, bordering the Bight of Biafra, between Cameroon and Gabon; composed of a mainland portion and five inhabited islands.	EQUATORIAL GUINEA
C16645	Country	GRC	Greece	A country in Southern Europe, bordering the Aegean Sea, Ionian Sea, and the Mediterranean Sea, between Albania and Turkey.	GREECE
C16647	Country	GRD	Grenada	An island between the Caribbean Sea and Atlantic Ocean, north of Trinidad and Tobago.	GRENADA
C16646	Country	GRL	Greenland	An island between the Arctic Ocean and the North Atlantic Ocean, northeast of Canada.	GREENLAND
C16654	Country	GTM	Guatemala	A country in Central America, bordering the Caribbean Sea, between Honduras and Belize and bordering the North Pacific Ocean, between El Salvador and Mexico.	GUATEMALA
C16593	Country	GUF	French Guiana	A country in Northern South America, bordering the North Atlantic Ocean, between Brazil and Suriname.	FRENCH GUIANA
C16652	Country	GUM	Guam	Island in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.	GUAM
C16657	Country	GUY	Guyana	A country in Northern South America, bordering the North Atlantic Ocean, between Suriname and Venezuela.	GUYANA
C16695	Country	HKG	Hong Kong	A special administrative region of China, bordering the South China Sea and China.	HONG KONG
C20106	Country	HMD	Heard Island and McDonald Islands	Islands in the Indian Ocean, about two-thirds of the way from Madagascar to Antarctica.	HEARD ISLAND AND MCDONALD ISLANDS
C16694	Country	HND	Honduras	A country in Central America, bordering the Caribbean Sea, between Guatemala and Nicaragua and bordering the North Pacific Ocean, between El Salvador and Nicaragua.	HONDURAS
C16474	Country	HRV	Croatia	A country in Southeastern Europe, bordering the Adriatic Sea, between Bosnia and Herzegovina and Slovenia.	CROATIA
C16660	Country	HTI	Haiti	A country comprising the western one-third of the island of Hispaniola, between the Caribbean Sea and the North Atlantic Ocean, west of the Dominican Republic.	HAITI
C16699	Country	HUN	Hungary	A country in Central Europe, northwest of Romania.	HUNGARY
C16728	Country	IDN	Indonesia	A country in Southeastern Asia, comprising the archipelago between the Indian Ocean and the Pacific Ocean.	INDONESIA
C16727	Country	IND	India	A country in Southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan.	INDIA
C16365	Country	IOT	British Indian Ocean Territory	An archipelago in the Indian Ocean, about one-half the way from Africa to Indonesia.	BRITISH INDIAN OCEAN TERRITORY
C16757	Country	IRL	Ireland	A country in Western Europe, occupying five-sixths of the island of Ireland in the North Atlantic Ocean, west of Great Britain.	IRELAND
C16755	Country	IRN	Iran	A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan.	IRAN
C16756	Country	IRQ	Iraq	A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait.	IRAQ
C16704	Country	ISL	Iceland	A country in Northern Europe, island between the Greenland Sea and the North Atlantic Ocean, northwest of the UK.	ICELAND
C16760	Country	ISR	Israel	A country in the Middle East, bordering the Mediterranean Sea, between Egypt and Lebanon.	ISRAEL
C16761	Country	ITA	Italy	A country in Southern Europe, occupying a peninsula extending into the central Mediterranean Sea, northeast of Tunisia.	ITALY
C16763	Country	JAM	Jamaica	An island in the Caribbean Sea, south of Cuba.	JAMAICA
C16765	Country	JOR	Jordan	A country in the Middle East, northwest of Saudi Arabia.	JORDAN
C16764	Country	JPN	Japan	A country in Eastern Asia, occupying an island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula.	JAPAN
C64374	Country	JRE	Jersey	Jersey and the other Channel Islands represent the last remnants of the medieval Dukedom of Normandy that held sway in both France and England. Jersey is a British crown dependency, but is not part of the UK.	JERSEY
C20107	Country	KAZ	Kazakhstan	A country in Central Asia, northwest of China.	KAZAKHSTAN
C16769	Country	KEN	Kenya	A country in Eastern Africa, bordering the Indian Ocean, between Somalia and Tanzania.	KENYA
C16771	Country	KGZ	Kyrgyzstan	A country in Central Asia, west of China.	KYRGYZSTAN
C16378	Country	KHM	Cambodia	A country in Southeastern Asia, bordering the Gulf of Thailand, between Thailand, Vietnam, and Laos.	CAMBODIA
C16639	Country	KIR	Kiribati	A group of 33 coral atolls in the Pacific Ocean, straddling the equator; the capital Tarawa is about one-half of the way from Hawaii to Australia.	KIRIBATI
C17885	Country	KNA	Saint Kitts and Nevis	Islands in the Caribbean Sea, about one-third of the way from Puerto Rico to Trinidad and Tobago.	SAINT KITTS AND NEVIS
C16774	Country	KOR	South Korea	A country in Eastern Asia, occupying the southern half of the Korean Peninsula, bordering the Sea of Japan and the Yellow Sea.	SOUTH KOREA
C16775	Country	KWT	Kuwait	A country in the Middle East, bordering the Persian Gulf, between Iraq and Saudi Arabia.	KUWAIT
C16780	Country	LAO	Lao People's Democratic Republic	A country in Southeastern Asia, northeast of Thailand, west of Vietnam.	LAO PEOPLE'S DEMOCRATIC REPUBLIC
C16784	Country	LBN	Lebanon	A country in the Middle East, bordering the Mediterranean Sea, between Israel and Syria.	LEBANON
C16791	Country	LBR	Liberia	A country in Western Africa, bordering the North Atlantic Ocean, between Cote d'Ivoire and Sierra Leone.	LIBERIA
C16793	Country	LBY	Libyan Arab Jamahiriya	A country in Northern Africa, bordering the Mediterranean Sea, between Egypt and Tunisia.	LIBYAN ARAB JAMAHIRIYA
C17113	Country	LCA	Saint Lucia	A country in the Caribbean, occupying an island between the Caribbean Sea and North Atlantic Ocean, north of Trinidad and Tobago.	SAINT LUCIA
C16794	Country	LIE	Liechtenstein	A country in Central Europe, between Austria and Switzerland.	LIECHTENSTEIN
C17163	Country	LKA	Sri Lanka	A country in Southern Asia, occupying an island in the Indian Ocean, south of India.	SRI LANKA
C16787	Country	LSO	Lesotho	A country in Southern Africa, an enclave of South Africa.	LESOTHO
C16799	Country	LTU	Lithuania	A country in Eastern Europe, bordering the Baltic Sea, between Latvia and Russia.	LITHUANIA
C16803	Country	LUX	Luxembourg	A country in Western Europe, between France, Belgium, and Germany.	LUXEMBOURG
C16783	Country	LVA	Latvia	A country in Eastern Europe, bordering the Baltic Sea, between Estonia and Lithuania.	LATVIA
C16807	Country	MAC	Macao	A country in Eastern Asia, bordering the South China Sea and China.	MACAO
C16878	Country	MAR	Morocco	A country in Northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, between Algeria and Western Sahara.	MOROCCO
C16874	Country	MCO	Monaco	A country in Western Europe, bordering the Mediterranean Sea on the southern coast of France, near the border with Italy.	MONACO
C16871	Country	MDA	Moldova	A country in Eastern Europe, northeast of Romania.	MOLDOVA, REPUBLIC OF
C16808	Country	MDG	Madagascar	A country in Southern Africa, occupying an island in the Indian Ocean, east of Mozambique.	MADAGASCAR
C16815	Country	MDV	Maldives	A country in Southern Asia, occupying a group of atolls in the Indian Ocean, south-southwest of India.	MALDIVES
C16850	Country	MEX	Mexico	A country in Central America, bordering the Caribbean Sea and the Gulf of Mexico, between Belize and the US and bordering the North Pacific Ocean, between Guatemala and the US.	MEXICO
C16822	Country	MHL	Marshall Islands	A group of atolls and reefs in the North Pacific Ocean, about one-half of the way from Hawaii to Australia.	MARSHALL ISLANDS
C17654	Country	MKD	Republic of Macedonia	A country in Southeastern Europe, north of Greece.	REPUBLIC OF MACEDONIA
C16816	Country	MLI	Mali	A country in Western Africa, southwest of Algeria.	MALI
C16817	Country	MLT	Malta	A country in Southern Europe, occupying islands in the Mediterranean Sea, south of Sicily (Italy).	MALTA
C16370	Country	MMR	Myanmar	A country in Southeastern Asia, bordering the Andaman Sea and the Bay of Bengal, between Bangladesh and Thailand.	MYANMAR
C64378	Country	MNE	Montenegro	A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).	MONTENEGRO
C16875	Country	MNG	Mongolia	A country in Northern Asia, between China and Russia.	MONGOLIA
C17882	Country	MNP	Northern Mariana Islands	A country in the Pacific, comprising islands in the North Pacific Ocean, about three-quarters of the way from Hawaii to the Philippines.	NORTHERN MARIANA ISLANDS
C16882	Country	MOZ	Mozambique	A country in Southern Africa, bordering the Mozambique Channel, between South Africa and Tanzania.	MOZAMBIQUE
C16826	Country	MRT	Mauritania	A country in Northern Africa, bordering the North Atlantic Ocean, between Senegal and Western Sahara.	MAURITANIA
C16876	Country	MSR	Montserrat	A country in the Caribbean, occupying an island in the Caribbean Sea, southeast of Puerto Rico.	MONTSERRAT
C16823	Country	MTQ	Martinique	An island in the Caribbean Sea, north of Trinidad and Tobago.	MARTINIQUE
C16827	Country	MUS	Mauritius	A country in Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.	MAURITIUS
C16813	Country	MWI	Malawi	A country in Southern Africa, east of Zambia.	MALAWI
C16814	Country	MYS	Malaysia	A country in Southeastern Asia, occupying a peninsula and the northern one-third of the island of Borneo, bordering Indonesia and the South China Sea, south of Vietnam.	MALAYSIA
C16828	Country	MYT	Mayotte	A country in Southern Africa, occupying an island in the Mozambique Channel, about one-half of the way from northern Madagascar to northern Mozambique.	MAYOTTE
C16891	Country	NAM	Namibia	A country in Southern Africa, bordering the South Atlantic Ocean, between Angola and South Africa.	NAMIBIA
C16913	Country	NCL	New Caledonia	A country in the Pacific, comprised of islands in the South Pacific Ocean, east of Australia.	NEW CALEDONIA
C16916	Country	NER	Niger	A country in Western Africa, southeast of Algeria.	NIGER
C16919	Country	NFK	Norfolk Island	A country in the Pacific, occupying an island in the South Pacific Ocean, east of Australia.	NORFOLK ISLAND
C16917	Country	NGA	Nigeria	A country in Western Africa, bordering the Gulf of Guinea, between Benin and Cameroon.	NIGERIA
C16915	Country	NIC	Nicaragua	A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Costa Rica and Honduras.	NICARAGUA
C16918	Country	NIU	Niue	A country in the Pacific, occupying an island in the South Pacific Ocean, east of Tonga.	NIUE
C16903	Country	NLD	Netherlands	A country in Western Europe, bordering the North Sea, between Belgium and Germany.	NETHERLANDS
C16920	Country	NOR	Norway	A country in Northern Europe, bordering the North Sea and the North Atlantic Ocean, west of Sweden.	NORWAY
C16901	Country	NPL	Nepal	A country in Southern Asia, between China and India.	NEPAL
C16896	Country	NRU	Nauru	A country in Oceania, occupying an island in the South Pacific Ocean, south of the Marshall Islands.	NAURU
C16914	Country	NZL	New Zealand	A country in the Pacific, comprised of islands in the South Pacific Ocean, southeast of Australia.	NEW ZEALAND
C16933	Country	OMN	Oman	A country in the Middle East, bordering the Arabian Sea, Gulf of Oman, and Persian Gulf, between Yemen and the United Arab Emirates.	OMAN
C16949	Country	PAK	Pakistan	A country in Southern Asia, bordering the Arabian Sea, between India on the east and Iran and Afghanistan on the west and China in the north.	PAKISTAN
C16951	Country	PAN	Panama	A country in Central America, bordering both the Caribbean Sea and the North Pacific Ocean, between Colombia and Costa Rica.	PANAMA
C16993	Country	PCN	Pitcairn Island	A country in the Pacific, comprised of islands in the South Pacific Ocean, about midway between Peru and New Zealand.	PITCAIRN
C16972	Country	PER	Peru	A country in Western South America, bordering the South Pacific Ocean, between Chile and Ecuador.	PERU
C16978	Country	PHL	Philippines	A country in Southeastern Asia, comprised of an archipelago between the Philippine Sea and the South China Sea, east of Vietnam.	PHILIPPINES
C17733	Country	PLW	Palau	A country in the Pacific, comprising a group of islands in the North Pacific Ocean, southeast of the Philippines.	PALAU
C16952	Country	PNG	Papua New Guinea	A country in Southeastern Asia, comprising a group of islands and including the eastern half of the island of New Guinea, between the Coral Sea and the South Pacific Ocean, east of Indonesia.	PAPUA NEW GUINEA
C17002	Country	POL	Poland	A country in Central Europe, east of Germany.	POLAND
C17043	Country	PRI	Puerto Rico	An island between the Caribbean Sea and the North Atlantic Ocean, east of the Dominican Republic.	PUERTO RICO
C16773	Country	PRK	North Korea	A country in Eastern Asia, occupying the northern half of the Korean Peninsula, bordering the Korea Bay and the Sea of Japan, between China and South Korea.	NORTH KOREA
C17006	Country	PRT	Portugal	A country in Southwestern Europe, bordering the North Atlantic Ocean, west of Spain.	PORTUGAL
C16953	Country	PRY	Paraguay	A country in Central South America, northeast of Argentina.	PARAGUAY
C20110	Country	PSE	Palestinian Territory, Occupied	A collective name for the West Bank and the Gaza Strip, two territories in Palestine.	PALESTINIAN TERRITORY, OCCUPIED
C16594	Country	PYF	French Polynesia	An archipelago in the South Pacific Ocean, about one-half of the way from South America to Australia.	FRENCH POLYNESIA
C17045	Country	QAT	Qatar	A country in the Middle East, occupying a peninsula bordering the Persian Gulf and Saudi Arabia.	QATAR
C17095	Country	REU	Reunion	An Southern Africa, occupying an island in the Indian Ocean, east of Madagascar.	REUNION
C17108	Country	ROU	Romania	A country in Southeastern Europe, bordering the Black Sea, between Bulgaria and Ukraine.	ROMANIA
C17111	Country	RUS	Russia	A country in Northern Asia (that part west of the Urals is sometimes included with Europe), bordering the Arctic Ocean, between Europe and the North Pacific Ocean.	RUSSIAN FEDERATION
C17112	Country	RWA	Rwanda	A country in Central Africa, east of Democratic Republic of the Congo.	RWANDA
C17117	Country	SAU	Saudi Arabia	A country in the Middle East, bordering the Persian Gulf and the Red Sea, north of Yemen.	SAUDI ARABIA
C64377	Country	SCG	Serbia	A republic in Southeastern Europe, bordering the Adriatic Sea, between Albania and Bosnia and Herzegovina. Formerly part of Serbia and Montenegro (Federation Republic of Yugoslavia).	SERBIA
C17170	Country	SDN	Sudan	A country in Northern Africa, bordering the Red Sea, between Egypt and Eritrea.	SUDAN
C17121	Country	SEN	Senegal	A country in Western Africa, bordering the North Atlantic Ocean, between Guinea-Bissau and Mauritania.	SENEGAL
C17134	Country	SGP	Singapore	A country in Southeastern Asia, comprised of islands between Malaysia and Indonesia.	SINGAPORE
C20111	Country	SGS	South Georgia and the South Sandwich Islands	A group of islands in the South Atlantic Ocean, east of the tip of South America.	SOUTH GEORGIA AND THE SOUTH SANDWICH ISLANDS
C17164	Country	SHN	Saint Helena	Islands in the South Atlantic Ocean, about midway between South America and Africa.	SAINT HELENA
C17178	Country	SJM	Svalbard and Jan Mayen	Islands between the Arctic Ocean, Barents Sea, Greenland Sea, and Norwegian Sea, northeast of Iceland and north of Norway.	SVALBARD AND JAN MAYEN
C17148	Country	SLB	Solomon Islands	A group of islands in the South Pacific Ocean, east of Papua New Guinea.	SOLOMON ISLANDS
C17130	Country	SLE	Sierra Leone	A country in Western Africa, bordering the North Atlantic Ocean, between Guinea and Liberia.	SIERRA LEONE
C16532	Country	SLV	El Salvador	A country in Central America, bordering the North Pacific Ocean, between Guatemala and Honduras.	EL SALVADOR
C17115	Country	SMR	San Marino	A country in Southern Europe, an enclave in central Italy.	SAN MARINO
C17149	Country	SOM	Somalia	A country in Eastern Africa, bordering the Gulf of Aden and the Indian Ocean, east of Ethiopia.	SOMALIA
C17165	Country	SPM	Saint Pierre and Miquelon	A country in Northern North America, comprised of islands in the North Atlantic Ocean, south of Newfoundland (Canada).	SAINT PIERRE AND MIQUELON
C17116	Country	STP	Sao Tome and Principe	A country in Western Africa, comprised of islands in the Gulf of Guinea, straddling the Equator, west of Gabon.	SAO TOME AND PRINCIPE
C17175	Country	SUR	Suriname	A country in Northern South America, bordering the North Atlantic Ocean, between French Guiana and Guyana.	SURINAME
C17669	Country	SVK	Slovakia	A country in Central Europe, south of Poland.	SLOVAKIA
C17138	Country	SVN	Slovenia	A country in Central Europe, bordering the Adriatic Sea, between Austria and Croatia.	SLOVENIA
C17180	Country	SWE	Sweden	A country in Northern Europe, bordering the Baltic Sea, Gulf of Bothnia, Kattegat, and Skagerrak, between Finland and Norway.	SWEDEN
C17179	Country	SWZ	Swaziland	A country in Southern Africa, between Mozambique and South Africa.	SWAZILAND
C17129	Country	SYC	Seychelles	A country in Eastern Africa, comprised of a group of islands in the Indian Ocean, northeast of Madagascar.	SEYCHELLES
C17182	Country	SYR	Syria	A country in the Middle East, bordering the Mediterranean Sea, between Lebanon and Turkey.	SYRIAN ARAB REPUBLIC
C17224	Country	TCA	Turks and Caicos Islands	Two island groups in the North Atlantic Ocean, southeast of The Bahamas.	TURKS AND CAICOS ISLANDS
C16412	Country	TCD	Chad	A country in Central Africa, south of Libya.	CHAD
C17202	Country	TGO	Togo	A country in Western Africa, bordering the Bight of Benin, between Benin and Ghana.	TOGO
C17192	Country	THA	Thailand	A country in Southeastern Asia, bordering the Andaman Sea and the Gulf of Thailand, southeast of Burma.	THAILAND
C17183	Country	TJK	Tajikistan	A country in Central Asia, west of China.	TAJIKISTAN
C17704	Country	TKL	Tokelau	A group of three atolls in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.	TOKELAU
C17223	Country	TKM	Turkmenistan	A country in Central Asia, bordering the Caspian Sea, between Iran and Kazakhstan.	TURKMENISTAN
C17200	Country	TLS	Timor-Leste	A country in Southeastern Asia, northwest of Australia in the Lesser Sunda Islands at the eastern end of the Indonesian archipelago. East Timor includes the eastern half of the island of Timor, the Oecussi (Ambeno) region on the northwest portion of the island of Timor, and the islands of Pulau Atauro and Pulau Jaco.	TIMOR-LESTE
C17205	Country	TON	Tonga	An archipelago in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.	TONGA
C17217	Country	TTO	Trinidad and Tobago	Islands between the Caribbean Sea and the North Atlantic Ocean, northeast of Venezuela.	TRINIDAD AND TOBAGO
C17221	Country	TUN	Tunisia	A country in Northern Africa, bordering the Mediterranean Sea, between Algeria and Libya.	TUNISIA
C17222	Country	TUR	Turkey	A country in southeastern Europe and southwestern Asia (that portion of Turkey west of the Bosporus is geographically part of Europe), bordering the Black Sea, between Bulgaria and Georgia, and bordering the Aegean Sea and the Mediterranean Sea, between Greece and Syria.	TURKEY
C17225	Country	TUV	Tuvalu	An island group consisting of nine coral atolls in the South Pacific Ocean, about one-half of the way from Hawaii to Australia.	TUVALU
C17184	Country	TWN	Taiwan	A group of islands bordering the East China Sea, Philippine Sea, South China Sea, and Taiwan Strait, north of the Philippines, off the southeastern coast of China.	TAIWAN
C17185	Country	TZA	Tanzania	A country in Eastern Africa, bordering the Indian Ocean, between Kenya and Mozambique.	TANZANIA, UNITED REPUBLIC OF
C17228	Country	UGA	Uganda	A country in Eastern Africa, west of Kenya.	UGANDA
C17229	Country	UKR	Ukraine	A country in Eastern Europe, bordering the Black Sea, between Poland and Russia.	UKRAINE
C20112	Country	UMI	United States Minor Outlying Islands	The U.S. Minor Outlying Islands consist of Baker Island, Howland Island, Jarvis Island, Johnston Atoll, Kingman Reef, Midway Island, Navassa Island, Palmyra Atoll, and Wake Island (Wake Atoll).	UNITED STATES MINOR OUTLYING ISLANDS
C17244	Country	URY	Uruguay	A country in Southern South America, bordering the South Atlantic Ocean, between Argentina and Brazil.	URUGUAY
C17234	Country	USA	United States	A country in North America, bordering both the North Atlantic Ocean and the North Pacific Ocean, between Canada and Mexico.	UNITED STATES
C17246	Country	UZB	Uzbekistan	A country in Central Asia, north of Afghanistan.	UZBEKISTAN
C17249	Country	VAT	Holy See	An enclave of Rome (Italy).	VATICAN CITY STATE
C17114	Country	VCT	Saint Vincent and the Grenadines	A country in the Caribbean, comprised of islands in the Caribbean Sea, north of Trinidad and Tobago.	SAINT VINCENT AND THE GRENADINES
C17250	Country	VEN	Venezuela	A country in Northern South America, bordering the Caribbean Sea and the North Atlantic Ocean, between Colombia and Guyana.	VENEZUELA
C17653	Country	VGB	British Virgin Islands	Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.	VIRGIN ISLANDS,BRITISH
C17255	Country	VIR	United States Virgin Islands	Islands between the Caribbean Sea and the North Atlantic Ocean, east of Puerto Rico.	VIRGIN ISLANDS, U.S.
C17252	Country	VNM	Vietnam	A country in Southeastern Asia, bordering the Gulf of Thailand, Gulf of Tonkin, and South China Sea, alongside China, Laos, and Cambodia.	VIETNAM
C17247	Country	VUT	Vanuatu	A group of islands in the South Pacific Ocean, about three-quarters of the way from Hawaii to Australia.	VANUATU
C17259	Country	WLF	Wallis and Futuna Islands	Islands in the South Pacific Ocean, about two-thirds of the way from Hawaii to New Zealand.	WALLIS AND FUTUNA
C17740	Country	WSM	Samoa	A group of islands in the South Pacific Ocean, about one-half of the way from Hawaii to New Zealand.	SAMOA
C17264	Country	YEM	Yemen	A country in the Middle East, bordering the Arabian Sea, Gulf of Aden, and Red Sea, between Oman and Saudi Arabia.	YEMEN
C17151	Country	ZAF	South Africa	A country in Southern Africa, at the southern tip of the continent of Africa.	SOUTH AFRICA
C17267	Country	ZMB	Zambia	A country in Southern Africa, east of Angola.	ZAMBIA
C17268	Country	ZWE	Zimbabwe	A country in Southern Africa, between South Africa and Zambia.	ZIMBABWE
C49650	Diagnosis Group	[TDIGRP]		A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)	Diagnosis Group
C49651	Diagnosis Group	HEALTHY SUBJECTS	Healthy Subject	An individual who is or becomes a participant in a research study and has no significant health-related issues.  (NCI)	
C50399	Dictionary Name	[DICTNAM]		A name given to a reference source that lists words and gives their meaning. (NCI)	Name of Dictionary
C49471	Dictionary Name	COSTART	Thesaurus of Adverse Reaction Term Coding Symbols	A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)	Coding Symbols for a Thesaurus of Adverse Reaction Terms
C49474	Dictionary Name	ICD	International Classification of Diseases	A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)	International Classification of Diseases
C49476	Dictionary Name	LOINC	Logical Observation Identifiers Names and Codes	Published by the The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)	Logical Observation Identifiers Names and Codes
C43820	Dictionary Name	MedDRA	MedDRA	MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)	Medical Dictionary for Regulatory Activities
C53489	Dictionary Name	SNOMED	Systematized Nomenclature of Medicine	A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)	Systematized Nomenclature of Medicine
C49468	Dictionary Name	WHOART	World Health Organization Adverse Reaction Terminology	A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)	World Health Organization Adverse Reaction Terms
C49475	Dictionary Name	WHODD	World Health Organization Drug Dictionary	A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)	World Health Organization Drug Dictionary
C49484	Not Done	[ND]		Indicates a task, process or examination that has either not been initiated or completed. (NCI)	Not Done; ND
C49484	Not Done	NOT DONE	Not Done	Indicates a task, process or examination that has either not been initiated or completed. (NCI)	Not Done; ND
C16564	Patient Ethnic Group	[ETHNIC]		A social group characterized by a distinctive social and cultural tradition maintained from generation to generation, a common history and origin and a sense of identification with the group; members of the group have distinctive features in their way of life, shared experiences and often a common genetic heritage; these features may be reflected in their experience of health and disease. (NCI)	Ethnicity
C16960	Patient Ethnic Group	[Patient]		A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary. (NCI)	
C17459	Patient Ethnic Group 	Hispanic or Latino	Hispanic or Latino	A person of Mexican, Puerto Rican, Cuban, Central or South American or other Spanish culture or origin, regardless of race.  (NCI)	
C41222	Patient Ethnic Group 	Not Hispanic or Latino	Not Hispanic or Latino	A person not of Cuban, Mexican, Puerto Rican, South or Central American, or other Spanish culture or origin, regardless of race. An arbitrary ethnic classification. (NCI)	
C43234	Patient Ethnic Group 	Not reported	Not Stated	Not provided or available	
C17998	Patient Ethnic Group 	U	Unknown	Not known, not observed, not recorded, or refused. (NCI)	UNKNOWN
C42636	Pharmaceutical Dosage Form	[FRM]		The form of the completed pharmaceutical product, e.g. tablet, capsule, injection, elixir, suppository. Dosage form can have a significant effect on the onset, duration and intensity of the pharmacological action of a drug. A pharmaceutical dosage form controls the rate at which the drug is released into the biological fluids. This release rate affects its intrinsic absorption pattern and therefore, the bioavailability of the drug.	Dose Form
C42887	Pharmaceutical Dosage Form	AEROSOL	Aerosol Dosage Form	A product that is packaged under pressure and contains therapeutically active ingredients that are released upon activation of an appropriate valve system; it is intended for topical application to the skin as well as local application into the nose (nasal aerosols), mouth (lingual aerosols), or lungs (inhalation aerosols). (FDA)	
C42888	Pharmaceutical Dosage Form	AEROSOL, FOAM	Aerosol Foam Dosage Form	A dosage form containing one or more active ingredients, surfactants, aqueous or non-aqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged. (FDA)	
C42960	Pharmaceutical Dosage Form	AEROSOL, METERED	Metered Aerosol Dosage Form	A pressurized dosage form consisting of metered dose valves which allow for the delivery of a uniform quantity of spray upon each activation. (NCI)	
C42971	Pharmaceutical Dosage Form	AEROSOL, POWDER	Powder Aerosol Dosage Form	A product that is packaged under pressure and contains therapeutically active ingredients, in the form of a powder, that are released upon activation of an appropriate valve system. (NCI)	
C42889	Pharmaceutical Dosage Form	AEROSOL, SPRAY	Aerosol Spray Dosage Form	An aerosol product which utilizes a compressed gas as the propellant to provide the force necessary to expel the product as a wet spray; it is applicable to solutions of medicinal agents in aqueous solvents. (NCI)	
C42892	Pharmaceutical Dosage Form	BAR, CHEWABLE	Chewable Bar Dosage Form	A solid dosage form usually in the form of a rectangle that is meant to be chewed. (NCI)	
C42890	Pharmaceutical Dosage Form	BEAD	Bead Dosage Form	A solid dosage form in the shape of a small ball. (NCI)	
C43451	Pharmaceutical Dosage Form	BEAD, IMPLANT, EXTENDED RELEASE	Extended Release Bead Implant Dosage Form	A small sterile solid mass consisting of a highly purified drug intended for implantation in the body which would allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form.  (NCI)	
C42891	Pharmaceutical Dosage Form	BLOCK	Block Dosage Form	Solid dosage form, usually in the shape of a square or rectangle. (NCI)	
C25158	Pharmaceutical Dosage Form	CAPSULE	Capsule Dosage Form	A solid pharmaceutical dosage form that contains medicinal agent within either a hard or soft soluble container or shell, usually used for the oral administration of medicine. The shells are made of a suitable form of gelatin or other substance. (NCI)	
C42895	Pharmaceutical Dosage Form	CAPSULE, COATED	Coated Capsule Dosage Form	A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating. (NCI)	
C42896	Pharmaceutical Dosage Form	CAPSULE, COATED PELLETS	Coated Pellets in Capsule Dosage Form	A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which varying amounts of coating have been applied. (NCI)	
C42917	Pharmaceutical Dosage Form	CAPSULE, COATED, EXTENDED RELEASE	Extended Release Coated Capsule Dosage Form	A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)	
C42902	Pharmaceutical Dosage Form	CAPSULE, DELAYED RELEASE	Delayed Release Capsule Dosage Form	A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)	
C42904	Pharmaceutical Dosage Form	CAPSULE, DELAYED RELEASE PELLETS	Delayed Release Pellets in Capsule Dosage Form	A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; the drug itself is in the form of granules to which enteric coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)	
C42916	Pharmaceutical Dosage Form	CAPSULE, EXTENDED RELEASE	Extended Release Capsule Dosage Form	A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)	
C42928	Pharmaceutical Dosage Form	CAPSULE, FILM COATED, EXTENDED RELEASE	Extended Release Film Coated Capsule Dosage Form	A solid dosage form in which the drug is enclosed within either a hard or soft soluble container or "shell" made from a suitable form of gelatin; additionally, the capsule is covered in a designated film coating, and which releases a drug (or drugs) in such a manner to allow at least a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)	
C42936	Pharmaceutical Dosage Form	CAPSULE, GELATIN COATED	Gelatin Coated Capsule Dosage Form	A solid dosage form in which the drug is enclosed within either a hard or soft soluble container made from a suitable form of gelatin; through a banding process, the capsule is coated with additional layers of gelatin so as to form a complete seal. (NCI)	
C42954	Pharmaceutical Dosage Form	CAPSULE, LIQUID FILLED	Liquid Filled Capsule Dosage Form	A solid dosage form in which the drug is enclosed within a soluble, gelatin shell which is plasticized by the addition of a polyol, such as sorbitol or glycerin, and is therefore of a somewhat thicker consistency than that of a hard shell capsule; typically, the active ingredients are dissolved or suspended in a liquid vehicle. (NCI)	
C45414	Pharmaceutical Dosage Form	CEMENT	Cement Dosage Form	A substance that serves to produce solid union between two surfaces. (NCI)	
C42678	Pharmaceutical Dosage Form	CIGARETTE	Cigarette Dosage Form	A narrow tube filled with material that is capable to burn with release of therapeutically-active substance(s) during the process of smoking. Cigarette is a very efficient drug-delivery inhaler system for fast-acting substances.(FDA)	
C60884	Pharmaceutical Dosage Form	CLOTH	Cloth Dosage Form	ALT_DEFINITION:  A large piece of relatively flat, absorbent material that contains a drug. It is typically used for applying medication or for cleansing. (FDA)	
C60891	Pharmaceutical Dosage Form	CONCENTRATE	Concentrate Dosage Form	A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration. (NCI)	
C42900	Pharmaceutical Dosage Form	CONE	Cone Dosage Form	A solid dosage form bounded by a circular base and the surface formed by line segments joining every point of the boundary of the base to a common vertex. A cone (usually containing antibiotics) is normally placed below the gingiva after a dental extraction. (NCI)	
C42919	Pharmaceutical Dosage Form	CORE, EXTENDED RELEASE	Extended Release Core Dosage Form	An ocular system placed in the eye from which the drug diffuses through a membrane at a constant rate over a specified period. (NCI)	
C28944	Pharmaceutical Dosage Form	CREAM	Cream Dosage Form	A semisolid emulsion of either the oil-in-water or the water-in-oil type, ordinarily intended for topical use. (NCI)	
C60897	Pharmaceutical Dosage Form	CREAM, AUGMENTED	Augmented Cream Dosage Form	A cream dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)	
C42901	Pharmaceutical Dosage Form	CRYSTAL	Crystal Dosage Form	A naturally produced angular solid of definite form in which the ultimate units from which it is built up are systematically arranged; they are usually evenly spaced on a regular space lattice.	
C45415	Pharmaceutical Dosage Form	CULTURE	Culture Dosage Form	The propagation of microorganisms or of living tissue cells in special media conducive to their growth. (NCI)	
C47890	Pharmaceutical Dosage Form	DIAPHRAGM	Diaphragm Dosage Form	A device usually dome-shaped, worn during copulation over the cervical mouth for prevention of conception or infection. (NCI)	
C43525	Pharmaceutical Dosage Form	DISC	Disc Dosage Form	A circular plate-like organ or structure. (FDA)	
C42679	Pharmaceutical Dosage Form	DOUCHE	Douche Dosage Form	A liquid preparation, intended for the irrigative cleansing of the vagina, that is prepared from powders, liquid solutions, or liquid concentrates and contains one or more chemical substances dissolved in a suitable solvent or mutually miscible solvents. (NCI)	
C42763	Pharmaceutical Dosage Form	DRESSING	Dressing Dosage Form	The application of various materials for protecting a wound.(FDA)	
C17423	Pharmaceutical Dosage Form	DRUG DELIVERY SYSTEM	Drug Delivery System	Modern technology, distributed with or as a part of a drug product that allows for the uniform release or targeting of drugs to the body. (FDA)	
C42912	Pharmaceutical Dosage Form	ELIXIR	Elixir Dosage Form	A clear, pleasantly flavored, sweetened hydroalcoholic liquid containing dissolved medicinal agents; it is intended for oral use. (NCI)	
C42913	Pharmaceutical Dosage Form	EMULSION	Emulsion Dosage Form	A dosage form consisting of a two-phase system comprised of at least two immiscible liquids (1), one of which is dispersed as droplets (internal or dispersed phase) within the other liquid (external or continuous phase), generally stabilized with one or more emulsifying agents. Note 1: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. Note 2: Emulsion is used as a dosage form term unless a more specific term is applicable, e.g. cream, lotion, ointment. (NCI)	
C42915	Pharmaceutical Dosage Form	ENEMA	Enema Dosage Form	A rectal preparation for therapeutic, diagnostic, or nutritive purposes.  (NCI)	
C42929	Pharmaceutical Dosage Form	EXTRACT	Extract Dosage Form	A concentrated preparation of vegetable or animal drugs obtained by removal of the active constituents of the respective drugs with a suitable menstrua, evaporation of all or nearly all of the solvent, and adjustment of the residual masses or powders to the prescribed standards. (NCI)	
C60926	Pharmaceutical Dosage Form	FIBER, EXTENDED RELEASE	Extended Release Fiber Dosage Form	A slender and elongated solid thread-like substance that delivers drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)	
C42932	Pharmaceutical Dosage Form	FILM	Film Dosage Form	A thin layer or coating. (NCI)	
C42920	Pharmaceutical Dosage Form	FILM, EXTENDED RELEASE	Extended Release Film Dosage Form	A drug delivery system in the form of a film that releases the drug over an extended period in such a way as to maintain constant drug levels in the blood or target tissue. (NCI)	
C42984	Pharmaceutical Dosage Form	FILM, SOLUBLE	Soluble Film Dosage Form	A thin layer or coating which is susceptible to being dissolved when in contact with a liquid. (NCI)	
C60927	Pharmaceutical Dosage Form	FOR SOLUTION	Dosage Form For Solution	A product, usually a solid, intended for solution prior to administration. (FDA)	
C60928	Pharmaceutical Dosage Form	FOR SUSPENSION	Dosage Form For Suspension	A product, usually a solid, intended for suspension prior to administration. (FDA)	
C60929	Pharmaceutical Dosage Form	FOR SUSPENSION, EXTENDED RELEASE	Extended Release Dosage Form For Suspension	A product, usually a solid, intended for suspension prior to administration; once the suspension is administered, the drug will be released at a constant rate over a specified period. (FDA)	
C42933	Pharmaceutical Dosage Form	GAS	Gas Dosage Form	Any elastic aeriform fluid in which the molecules are separated from one another and have free paths. (NCI)	
C42934	Pharmaceutical Dosage Form	GEL	Gel Dosage Form	A semisolid (1) dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion (2).  A gel may contain suspended particles. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature.  It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: A colloidal dispersion is a system in which particles of colloidal dimension (i.e., typically between 1 nm and 1 micrometer) are distributed uniformly throughout a liquid. (NCI)	
C42906	Pharmaceutical Dosage Form	GEL, DENTIFRICE	Dentifrice Gel Dosage Form	A combination of a dentifrice (formulation intended to clean and/or polish the teeth, and which may contain certain additional agents), and a gel. It is used with a toothbrush for the purpose of cleaning and polishing the teeth. (NCI)	
C60930	Pharmaceutical Dosage Form	GEL, METERED	Metered Gel Dosage Form	A gel preparation, with metered dose valves, which allow for the delivery of a uniform quantity of gel upon each activation. (FDA)	
C48193	Pharmaceutical Dosage Form	GENERATOR	Generator Dosage Form	An apparatus for the formation of vapor or gas from a liquid or solid by heat or chemical action. The term GENERATOR also applies to radioactive columns from which radionuclides are provided. (NCI)	
C42937	Pharmaceutical Dosage Form	GLOBULE	Globule Dosage Form	Also called pellets or pilules, are made of pure sucrose, lactose, or other polysaccharides. They are formed into small globular masses of various sizes, and are medicated by placing them in a vial and adding the liquid drug attenuation in the proportion not less than one percent (v/w). After shaking, the medicated globules are dried at temperatures not to exceed 40 degrees Centigrade. (NCI)	
C45416	Pharmaceutical Dosage Form	GRAFT	Graft Dosage Form	A slip of skin or of other tissue for implantation. (NCI)	
C42938	Pharmaceutical Dosage Form	GRANULE	Granule Dosage Form	A small particle or grain. (NCI)	
C42903	Pharmaceutical Dosage Form	GRANULE, DELAYED RELEASE	Delayed Release Granule Dosage Form	A small medicinal particle or grain to which an enteric or other coating has been applied, thus delaying release of the drug until its passage into the intestines. (NCI)	
C42909	Pharmaceutical Dosage Form	GRANULE, EFFERVESCENT	Effervescent Granule Dosage Form	A small particle or grain containing a medicinal agent in a dry mixture usually composed of sodium bicarbonate, citric acid, and tartaric acid which, when in contact with water, has the capability to release gas, resulting in effervescence. (NCI)	
C42939	Pharmaceutical Dosage Form	GRANULE, FOR SOLUTION	Granule For Solution Dosage Form	A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)	
C42940	Pharmaceutical Dosage Form	GRANULE, FOR SUSPENSION	Granule For Suspension Dosage Form	A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the granules are so prepared to contain not only the medicinal agent, but the colorants, flavorants, and any other desired pharmaceutic ingredient. (NCI)	
C42921	Pharmaceutical Dosage Form	GRANULE, FOR SUSPENSION, EXTENDED RELEASE	Extended Release Granule For Suspension Dosage Form	A small medicinal particle or grain made available in its more stable dry form, to be reconstituted with solvent just before dispensing to form a suspension; the extended release system achieves slow release of the drug over an extended period of time and maintains constant drug levels in the blood or target tissue. (NCI)	
C42941	Pharmaceutical Dosage Form	GUM	Gum Dosage Form	A mucilaginous excretion from various plants. (NCI)	
C42894	Pharmaceutical Dosage Form	GUM, CHEWING	Chewing Gum Dosage Form	A sweetened and flavored insoluble plastic material of various shapes which when chewed, releases a drug substance into the oral cavity. (NCI)	
C42978	Pharmaceutical Dosage Form	GUM, RESIN	Resin Gum Dosage Form	Natural mixture of gum and resin, usually obtained as exudations from plants. (NCI)	
C42942	Pharmaceutical Dosage Form	IMPLANT	Implant Dosage Form	A material containing drug intended to be inserted securely and deeply in a living site for growth, slow release, or formation of an organic union. (NCI)	
C42944	Pharmaceutical Dosage Form	INHALANT	Inhalant Dosage Form	A special class of inhalations consisting of a drug or combination of drugs, that by virtue of their high vapor pressure, can be carried by an air current into the nasal passage where they exert their effect; the container from which the inhalant generally is administered is known as an inhaler. (NCI)	
C60931	Pharmaceutical Dosage Form	INJECTABLE, LIPOSOMAL	Liposomal Injection Dosage Form	An injection, which either consists of or forms liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance). (FDA)	
C42946	Pharmaceutical Dosage Form	INJECTION	Injectable Dosage Form	A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP. (NCI)	
C42914	Pharmaceutical Dosage Form	INJECTION, EMULSION	Emulsion for Injection Dosage Form	An emulsion consisting of a sterile, pyrogen-free preparation intended to be administered parenterally.(FDA)	
C42950	Pharmaceutical Dosage Form	INJECTION, LIPID COMPLEX	Injectable Lipid Complex Dosage Form	[definition pending](FDA)	
C42974	Pharmaceutical Dosage Form	INJECTION, POWDER, FOR SOLUTION	Powder For Injectable Solution Dosage Form	A sterile preparation intended for reconstitution to form a solution for parenteral use. (NCI)	
C42976	Pharmaceutical Dosage Form	INJECTION, POWDER, FOR SUSPENSION	Powder For Injectable Suspension Dosage Form	A sterile preparation intended for reconstitution to form a suspension for parenteral use. (NCI)	
C42977	Pharmaceutical Dosage Form	INJECTION, POWDER, FOR SUSPENSION, EXTENDED RELEASE	Powder For Injectable Extended Release Suspension Dosage Form	A dried preparation intended for reconstitution to form a suspension for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution).(FDA)	
C42959	Pharmaceutical Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR LIPOSOMAL SUSPENSION	Lyophilized Powder For Injectable Liposomal Suspension Dosage Form	A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner that would allow liposomes (a lipid bilayer vesicle usually composed of phospholipids which is used to encapsulate an active drug substance, either within a lipid bilayer or in an aqueous space) to be formed upon reconstitution. (NCI)	
C42957	Pharmaceutical Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	Lyophilized Powder For Injectable Solution Dosage Form	A dosage form intended for the solution prepared by lyophilization ('freeze drying'), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections. (NCI)	
C42958	Pharmaceutical Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION	Lyophilized Powder For Injectable Suspension Dosage Form	A liquid preparation, intended for parenteral use, that contains solids suspended in a suitable fluid medium and conforms in all respects to the requirements for Sterile Suspensions; the medicinal agents intended for the suspension are prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures. (NCI)	
C42956	Pharmaceutical Dosage Form	INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION, EXTENDED RELEASE	Lyophilized Powder For Extended Release Injectable Suspension Dosage Form	A sterile freeze dried preparation intended for reconstitution for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution). (NCI)	
C42945	Pharmaceutical Dosage Form	INJECTION, SOLUTION	Injectable Solution Dosage Form	A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection. (NCI)	
C42899	Pharmaceutical Dosage Form	INJECTION, SOLUTION, CONCENTRATE	Concentrate for Injectable Solution Dosage Form	A sterile preparation for parenteral use which, upon the addition of suitable solvents, yields a solution conforming in all respects to the requirements for Injections. (NCI)	
C42995	Pharmaceutical Dosage Form	INJECTION, SUSPENSION	Injectable Suspension Dosage Form	A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa. (NCI)	
C42926	Pharmaceutical Dosage Form	INJECTION, SUSPENSION, EXTENDED RELEASE	Injectable Extended Release Suspension Dosage Form	A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)	
C42951	Pharmaceutical Dosage Form	INJECTION, SUSPENSION, LIPOSOMAL	Injectable Liposomal Suspension Dosage Form	A liquid parenteral pharmaceutical dosage form structured as a multilamellar composition of concentric phospholipid spheres that encapsulate the drug (drug delivery systems) separated by layers of water. Drug release is facilitated and controlled by in vivo erosion of the liposomes. To further increase the in vivo circulation time, liposomes in some preparations are covalently derivatized with PEG to produce PEGylated or stealth liposomes. Covalent attachment of drugs to the outer surface of liposomes can potentially serve as a delayed-release product. (NCI)	
C42988	Pharmaceutical Dosage Form	INJECTION, SUSPENSION, SONICATED	Injectable Sonicated Suspension Dosage Form	A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. In addition, the product is sonicated while a gas is bubbled through the suspension, and this results in the formation of microspheres by the solid particles. (NCI)	
C60933	Pharmaceutical Dosage Form	INSERT	Insert Dosage Form	A specially formulated and shaped non-encapsulated solid preparation intended to be placed into a non-rectal orifice of the body, where drug is released, generally for localized effects. (FDA)	
C42922	Pharmaceutical Dosage Form	INSERT, EXTENDED RELEASE	Extended Release Insert Dosage Form	A specially formulated and shaped solid preparation (e.g., ring, tablet, or stick) intended to be placed in the vagina by special inserters, where the medication is released, generally for localized effects; the extended release preparation is designed to allow a reduction in dosing frequency. (NCI)	
C47915	Pharmaceutical Dosage Form	INTRAUTERINE DEVICE	Intrauterine Device Dosage Form	A device inserted and left in the uterus to prevent effective conception. (NCI)	
C42947	Pharmaceutical Dosage Form	IRRIGANT	Irrigant Dosage Form	A sterile solution intended to bathe or flush open wounds or body cavities; they're used topically, never parenterally. (NCI)	
C42948	Pharmaceutical Dosage Form	JELLY	Jelly Dosage Form	A class of gels--semisolid systems which consist of suspensions made up of either small inorganic particles or large organic molecules interpenetrated by a liquid--in which the structural coherent matrix contains a high portion of liquid, usually water. (NCI)	
C47916	Pharmaceutical Dosage Form	KIT	Kit Dosage Form	A packaged collection of related material. (NCI)	
C45413	Pharmaceutical Dosage Form	LINER, DENTAL	Dental Liner Dosage Form	A material applied to the inside of the dental cavity, for protection or insulation of the surface.(FDA)	
C42949	Pharmaceutical Dosage Form	LINIMENT	Liniment Dosage Form	A solution or mixture of various substances in oil, alcoholic solutions of soap, or emulsions intended for external application. (NCI)	
C42952	Pharmaceutical Dosage Form	LIPSTICK	Lipstick Dosage Form	A waxy solid, usually colored cosmetic, in stick form for the lips. (NCI)	
C42953	Pharmaceutical Dosage Form	LIQUID	Liquid Dosage Form	A dosage form consisting of a pure chemical in its liquid state. This dosage form term should not be applied to solutions. Note: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior.(FDA)	
C60934	Pharmaceutical Dosage Form	LIQUID, EXTENDED RELEASE	Extended Release Liquid Dosage Form	A liquid that delivers a drug in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (FDA)	
C29167	Pharmaceutical Dosage Form	LOTION	Lotion Dosage Form	An emulsion, liquid (1) dosage form. This dosage form is generally for external application to the skin (2). Note 1: A liquid is pourable; it flows and conforms to its container at room temperature.  It displays Newtonian or pseudoplastic flow behavior. Note 2: Previously the definition of a lotion was: The term lotion has been used to categorize many topical suspensions, solutions, and emulsions intended for application to the skin. The current definition of a lotion is restricted to an emulsion. (FDA)	
C60957	Pharmaceutical Dosage Form	LOTION. AUGMENTED	Augmented Lotion Dosage Form	A lotion dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)	
C60958	Pharmaceutical Dosage Form	LOTION/SHAMPOO	Lotion Shampoo Dosage Form	A lotion dosage form which has a soap or detergent that is usually used to clean the hair and scalp; it is often used as a vehicle for dermatologic agents. (FDA)	
C42955	Pharmaceutical Dosage Form	LOZENGE	Lozenge Dosage Form	A solid preparation containing one or more medicaments, usually in a flavored, sweetened base which is intended to dissolve or disintegrate slowly in the mouth. A lollipop is a lozenge on a stick.(FDA)	
C29269	Pharmaceutical Dosage Form	MOUTHWASH	Mouthwash Dosage Form	An aqueous solution which is most often used for its deodorant, refreshing, or antiseptic effect. (NCI)	
C48624	Pharmaceutical Dosage Form	NOT APPLICABLE	Dosage Form Not Applicable	The use of a dosage form term is not relevant or appropriate. (NCI)	
C42965	Pharmaceutical Dosage Form	OIL	Oil Dosage Form	An unctuous, combustible substance which is liquid, or easily liquefiable, on warming, and is soluble in ether but insoluble in water. Such substances, depending on their origin, are classified as animal, mineral, or vegetable oils. (NCI)	
C42966	Pharmaceutical Dosage Form	OINTMENT	Ointment Dosage Form	A suspension or emulsion, semisolid (1) dosage form, usually containing < 20% water and volatiles (2) and > 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note 1: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. Note 2: Percent water and volatiles are measured by a loss on drying test in which the sample is heated at 105 degrees C until constant weight is achieved. (NCI)	
C60984	Pharmaceutical Dosage Form	OINTMENT, AUGMENTED	Augmented Ointment Dosage Form	An ointment dosage form that enhances drug delivery. Augmentation does not refer to the strength of the drug in the dosage form. NOTE: CDER has decided to refrain from expanding the use of this dosage form due to difficulties in setting specific criteria that must be met to be considered augmented. (FDA)	
C47887	Pharmaceutical Dosage Form	PACKING	Packing Dosage Form	A material, usually covered by or impregnated with a drug, that is inserted into a body cavity or between the tooth enamel and the gingival margin.(FDA)	
C42967	Pharmaceutical Dosage Form	PASTE	Paste Dosage Form	A semisolid dosage form, containing a large proportion (20 - 50%) of solids finely dispersed in a fatty vehicle. This dosage form is generally for external application to the skin or mucous membranes. Note: A semisolid is not pourable; it does not flow or conform to its container at room temperature. It does not flow at low shear stress and generally exhibits plastic flow behavior. (NCI)	
C42907	Pharmaceutical Dosage Form	PASTE, DENTIFRICE	Dentifrice Paste Dosage Form	A paste formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)	
C60985	Pharmaceutical Dosage Form	PASTILLE	Pastille Dosage Form	An aromatic preparation, often with a pleasing flavor, usually intended to dissolve in the mouth. (FDA)	
C42968	Pharmaceutical Dosage Form	PATCH	Patch Dosage Form	A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body.  Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch.  Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body.  A patch is sometimes synonymous with the terms Extended Release Film and System. (NCI)	
C42923	Pharmaceutical Dosage Form	PATCH, EXTENDED RELEASE	Extended Release Patch Dosage Form	A drug delivery system in the form of a patch that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)	
C42911	Pharmaceutical Dosage Form	PATCH, EXTENDED RELEASE, ELECTRICALLY CONTROLLED	Electrically Controlled Extended Release Patch Dosage Form	A drug delivery system in the form of a patch which is controlled by an electric current that releases the drug in such a manner that a reduction in dosing frequency compared to that drug presented as a conventional dosage form (e.g., a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)	
C42969	Pharmaceutical Dosage Form	PELLET	Pellet Dosage Form	A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding. (NCI)	
C42943	Pharmaceutical Dosage Form	PELLET, IMPLANTABLE	Implantable Pellet Dosage Form	A small sterile solid mass consisting of a highly purified drug (with or without excipients) made by the formation of granules, or by compression and molding; they are intended for implantation in the body (usually subcutaneously) for the purpose of providing continuous release of the drug over long periods of time. (NCI)	
C42918	Pharmaceutical Dosage Form	PELLETS, COATED, EXTENDED RELEASE	Extended Release Coated Pellets Dosage Form	A solid dosage form in which the drug itself is in the form of granules to which varying amounts of coating have been applied, and which releases a drug (or drugs) in such a manner to allow a reduction in dosing frequency as compared to that drug (or drugs) presented as a conventional dosage form. (NCI)	
C25394	Pharmaceutical Dosage Form	PILL	Pill Dosage Form	A dose of medicine in the form of a small pellet. (NCI)	
C42970	Pharmaceutical Dosage Form	PLASTER	Plaster Dosage Form	Substance intended for external application made of such materials and of such consistency as to adhere to the skin and attach to a dressing; plasters are intended to afford protection and support and/or to furnish an occlusion and macerating action and to bring medication into close contact with the skin. (NCI)	
C47913	Pharmaceutical Dosage Form	POULTICE	Poultice Dosage Form	A soft, moist mass of meal, herbs, seed, etc., usually applied hot in cloth that consists of gruel-like consistency. (NCI)	
C42972	Pharmaceutical Dosage Form	POWDER	Powder Dosage Form	An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use. (NCI)	
C42908	Pharmaceutical Dosage Form	POWDER, DENTIFRICE	Dentifrice Powder Dosage Form	A powder formulation intended to clean and/or polish the teeth, and which may contain certain additional agents. (NCI)	
C42973	Pharmaceutical Dosage Form	POWDER, FOR SOLUTION	Powder for Solution Dosage Form	An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a solution. (NCI)	
C42975	Pharmaceutical Dosage Form	POWDER, FOR SUSPENSION	Powder for Suspension Dosage Form	An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle). (NCI)	
C42961	Pharmaceutical Dosage Form	POWDER, METERED	Metered Powder Dosage Form	A powder dosage form that is situated inside a container that has a mechanism to deliver a specified quantity. (NCI)	
C60988	Pharmaceutical Dosage Form	RING	Ring Dosage Form	A small circular object with a vacant circular center that is usually intended to be placed in the body by special inserters, where the medication is released, generally for localized effects. (FDA)	
C42979	Pharmaceutical Dosage Form	RINSE	Rinse Dosage Form	A liquid used to cleanse by flushing. (NCI)	
C42980	Pharmaceutical Dosage Form	SALVE	Salve Dosage Form	A thick ointment or cerate (a fat or wax based preparation with a consistency between an ointment and a plaster). (NCI)	
C42981	Pharmaceutical Dosage Form	SHAMPOO	Shampoo Dosage Form	A liquid soap or detergent used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)	
C42982	Pharmaceutical Dosage Form	SHAMPOO, SUSPENSION	Shampoo Suspension Dosage Form	A liquid soap or detergent containing one or more solid, insoluble substances dispersed in a liquid vehicle that is used to clean the hair and scalp and is often used as a vehicle for dermatologic agents. (NCI)	
C42983	Pharmaceutical Dosage Form	SOAP	Soap Dosage Form	Any compound of one or more fatty acids, or their equivalents, with an alkali; soap is detergent and is much employed in liniments, enemas, and in making pills. It is also a mild aperient, antacid and antiseptic. (NCI)	
C42986	Pharmaceutical Dosage Form	SOLUTION	Solution Dosage Form	A clear, homogeneous liquid dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior. (NCI)	
C42898	Pharmaceutical Dosage Form	SOLUTION, CONCENTRATE	Concentrate for Solution Dosage Form	A liquid preparation (i.e., a substance that flows readily in its natural state) that contains a drug dissolved in a suitable solvent or mixture of mutually miscible solvents; the drug has been strengthened by the evaporation of its non-active parts. (NCI)	
C42987	Pharmaceutical Dosage Form	SOLUTION, FOR SLUSH	Solution For Slush Dosage Form	A solution for the preparation of an iced saline slush, which is administered by irrigation and used to induce regional hypothermia (in conditions such as certain open heart and kidney surgical procedures) by its direct application. (NCI)	
C60994	Pharmaceutical Dosage Form	SOLUTION, GEL FORMING / DROPS	Gel Forming Drops Solution Dosage Form	A solution, which after usually being administered in a drop-wise fashion, forms a gel. (FDA)	
C42935	Pharmaceutical Dosage Form	SOLUTION, GEL FORMING, EXTENDED RELEASE	Extended Release Gel Forming Solution Dosage Form	A solution that forms a gel when it comes in contact with ocular fluid, and which allows at least a reduction in dosing frequency	
C60992	Pharmaceutical Dosage Form	SOLUTION/ DROPS	Drops Solution Dosage Form	A solution which is usually administered in a drop-wise fashion. (FDA)	
C47912	Pharmaceutical Dosage Form	SPONGE	Sponge Dosage Form	A porous, interlacing, absorbent material that contains a drug.  It is typically used for applying or introducing medication, or for cleansing.  A sponge usually retains its shape.(FDA)	
C42989	Pharmaceutical Dosage Form	SPRAY	Spray Dosage Form	A liquid minutely divided as by a jet of air or steam. (NCI)	
C42962	Pharmaceutical Dosage Form	SPRAY, METERED	Metered Spray Dosage Form	A non-pressurized dosage form consisting of valves which allow the dispensing of a specified quantity of spray upon each activation. (NCI)	
C42990	Pharmaceutical Dosage Form	SPRAY, SUSPENSION	Spray Suspension Dosage Form	A liquid preparation containing solid particles dispersed in a liquid vehicle and in the form of coarse droplets or as finely divided solids to be applied locally, most usually to the nasal-pharyngeal tract, or topically to the skin. (NCI)	
C42991	Pharmaceutical Dosage Form	STICK	Stick Dosage Form	A dosage form prepared in a relatively long and slender often cylindrical form. (NCI)	
C47914	Pharmaceutical Dosage Form	STRIP	Strip Dosage Form	A long narrow piece of material.	
C42993	Pharmaceutical Dosage Form	SUPPOSITORY	Suppository Dosage Form	A solid body of various weights and shapes, adapted for introduction into the rectal, vaginal, or urethral orifice of the human body; they usually melt, soften, or dissolve at body temperature. (NCI)	
C42924	Pharmaceutical Dosage Form	SUPPOSITORY, EXTENDED RELEASE	Extended Release Suppository Dosage Form	A drug delivery system in the form of a suppository that allows at least a reduction in dosing frequency. (NCI)	
C42994	Pharmaceutical Dosage Form	SUSPENSION	Suspension Dosage Form	A liquid dosage form that contains solid particles dispersed in a liquid vehicle. Note: A liquid is pourable; it flows and conforms to its container at room temperature. It displays Newtonian or pseudoplastic flow behavior.(FDA)	
C42925	Pharmaceutical Dosage Form	SUSPENSION, EXTENDED RELEASE	Extended Release Suspension Dosage Form	A liquid preparation consisting of solid particles dispersed throughout a liquid phase in which the particles are not soluble; the suspension has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form). (NCI)	
C60995	Pharmaceutical Dosage Form	SUSPENSION/DROPS	Drops Suspension Dosage Form	A suspension which is usually administered in a dropwise fashion. (FDA)	
C47889	Pharmaceutical Dosage Form	SUTURE	Suture Dosage Form	A strand or fiber used to hold wound edges in apposition during healing. (NCI)	
C47898	Pharmaceutical Dosage Form	SWAB	Swab Dosage Form	A small piece of relatively flat absorbent material that contains a drug.  A swab may also be attached to one end of a small stick.  A swab is typically used for applying medication or for cleansing. (NCI)	
C42996	Pharmaceutical Dosage Form	SYRUP	Syrup Dosage Form	An oral solution containing high concentrations of sucrose or other sugars; the term has also been used to include any other liquid dosage form prepared in a sweet and viscid vehicle, including oral suspensions.  (NCI)	
C42998	Pharmaceutical Dosage Form	TABLET	Tablet Dosage Form	A solid dosage form containing medicinal substances with or without suitable diluents.  (NCI)	
C42893	Pharmaceutical Dosage Form	TABLET, CHEWABLE	Chewable Tablet Dosage Form	A solid dosage form containing medicinal substances with or without suitable diluents that is intended to be chewed, producing a pleasant tasting residue in the oral cavity that is easily swallowed and does not leave a bitter or unpleasant after-taste. (NCI)	
C42897	Pharmaceutical Dosage Form	TABLET, COATED	Coated Tablet Dosage Form	A solid dosage form that contains medicinal substances with or without suitable diluents and is covered with a designated coating. (NCI)	
C60997	Pharmaceutical Dosage Form	TABLET, COATED PARTICLES	Tablet Coated Particles Dosage Form	A solid dosage form containing a conglomerate of medicinal particles that have each been covered with a coating. (FDA)	
C42905	Pharmaceutical Dosage Form	TABLET, DELAYED RELEASE	Delayed Release Tablet Dosage Form	A solid dosage form which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms. (NCI)	
C42997	Pharmaceutical Dosage Form	TABLET, DELAYED RELEASE PARTICLES	Delayed Release Particles Tablet Dosage Form	A solid dosage form containing a conglomerate of medicinal particles that have been covered with a coating which releases a drug (or drugs) at a time other than promptly after administration. Enteric-coated articles are delayed release dosage forms.  (NCI)	
C42910	Pharmaceutical Dosage Form	TABLET, EFFERVESCENT	Effervescent Tablet Dosage Form	A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.(FDA)	
C42927	Pharmaceutical Dosage Form	TABLET, EXTENDED RELEASE	Extended Release Tablet Dosage Form	A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form. (NCI)	
C42931	Pharmaceutical Dosage Form	TABLET, FILM COATED	Film Coated Tablet Dosage Form	A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer. (NCI)	
C42930	Pharmaceutical Dosage Form	TABLET, FILM COATED, EXTENDED RELEASE	Film Coated Extended Release Tablet Dosage Form	A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer; the tablet is formulated in such manner as to make the contained medicament available over an extended period of time following ingestion. (NCI)	
C61004	Pharmaceutical Dosage Form	TABLET, FOR SOLUTION	Tablet For Solution Dosage Form	A tablet that forms a solution when placed in a liquid. (FDA)	
C61005	Pharmaceutical Dosage Form	TABLET, FOR SUSPENSION	Tablet For Suspension Dosage Form	A tablet that forms a suspension when placed in a liquid (formerly referred to as a Dispersible Tablet).	TABLET, DISPERSIBLE
C42964	Pharmaceutical Dosage Form	TABLET, MULTILAYER	Multilayered Tablet Dosage Form	A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell. (NCI)	
C42963	Pharmaceutical Dosage Form	TABLET, MULTILAYER, EXTENDED RELEASE	Multilayered Extended Release Tablet Dosage Form	A solid dosage form containing medicinal substances that have been compressed to form a multiple-layered tablet or a tablet-within-a-tablet, the inner tablet being the core and the outer portion being the shell, which, additionally, is covered in a designated coating; the tablet is formulated in such manner as to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form. (NCI)	
C42999	Pharmaceutical Dosage Form	TABLET, ORALLY DISINTEGRATING	Orally Disintegrating Tablet Dosage Form	A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue.  (NCI)	
C61006	Pharmaceutical Dosage Form	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE	Tablet Orally Disintegrating Delayed Release Dosage Form	A solid dosage form containing medicinal substances which disintegrates rapidly, usually within a matter of seconds, when placed upon the tongue, but which releases a drug (or drugs) at a time other than promptly after administration. (FDA)	
C42985	Pharmaceutical Dosage Form	TABLET, SOLUBLE	Soluble Tablet Dosage Form	A solid dosage form that contains medicinal substances with or without suitable diluents and possesses the ability to dissolve in fluids. (NCI)	
C42992	Pharmaceutical Dosage Form	TABLET, SUGAR COATED	Sugar Coated Tablet Dosage Form	A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a colored or an uncolored water-soluble sugar. (NCI)	
C47892	Pharmaceutical Dosage Form	TAMPON	Tampon Dosage Form	A plug made of cotton, sponge, or oakum variously used in surgery to plug the nose, vagina, etc., for the control of hemorrhage or the absorption of secretions. (NCI)	
C47897	Pharmaceutical Dosage Form	TAPE	Tape Dosage Form	A narrow woven fabric, or a narrow extruded synthetic (such as plastic), usually with an adhesive on one or both sides. (NCI)	
C43000	Pharmaceutical Dosage Form	TINCTURE	Tincture Dosage Form	An alcoholic or hydroalcoholic solution prepared from vegetable materials or from chemical substances.  (NCI)	
C43001	Pharmaceutical Dosage Form	TROCHE	Troche Dosage Form	A discoid-shaped solid containing the medicinal agent in a suitably flavored base; troches are placed in the mouth where they slowly dissolve, liberating the active ingredients.  (NCI)	
C43002	Pharmaceutical Dosage Form	UNASSIGNED	Unassigned Dosage Form	A dosage form has yet to be assigned.  (NCI)	
C43003	Pharmaceutical Dosage Form	WAFER	Wafer Dosage Form	A thin slice of material containing a medicinal agent.  (NCI)	
C49627	Reason for Non-Completion	[NCOMPLT]		The reason that a subject was discontinued from a clinical trial.	Completion/Reason for Non-Completion
C41331	Reason for Non-Completion	ADVERSE EVENT	Adverse Event	Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event (AE) can therefore be any unintended sign (including an abnormal laboratory finding), symptom,or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the medicinal (investigational) product. NOTE: For further information, see the ICH Guideline for Clinical Safety Data Management: Definitions and Standards for Expedited Reporting. “[Modified from ICH E2A]” Synonyms: side effect, adverse experience. See also serious adverse event, serious adverse experience.  (CDISC glossary)	
C25250	Reason for Non-Completion	COMPLETED	Complete	To possess every necessary or normal part or component or step; having come or been brought to a conclusion. (NCI)	
C28554	Reason for Non-Completion	DEATH	Death	The absence of life or state of being dead. (NCI)	
C48226	Reason for Non-Completion	LACK OF EFFICACY	Lack of Efficacy	The lack of expected or desired effect related to a therapy. (NCI)	
C48227	Reason for Non-Completion	LOST TO FOLLOW-UP	Lost To Follow-up	The loss or lack of continuation of follow-up after a study has officially closed.  See Follow-up. (NCI)	
C49631	Reason for Non-Completion	NON-COMPLIANCE WITH STUDY DRUG	Non-Compliance With Study Drug	An indication that a subject has not agreed with or followed the instructions related to the study medication. (NCI)	
C17649	Reason for Non-Completion	OTHER	Other	Different than the one(s) previously specified or mentioned. (NCI)	
C48250	Reason for Non-Completion	PHYSICIAN DECISION	Physician Decision	A position, opinion or judgment reached after consideration by a physician with reference to subject. (NCI)	
C25742	Reason for Non-Completion	PREGNANCY	Pregnancy	Pregnancy is the state or condition of having a developing embryo or fetus in the body (uterus), after union of an ovum and spermatozoon, during the period from conception to birth. (NCI)	
C35571	Reason for Non-Completion	PROGRESSIVE DISEASE	Progressive Disease	A disease process that is increasing in scope or severity. (NCI)	
C48251	Reason for Non-Completion	PROTOCOL VIOLATION	Protocol Violation	An event or decision that stands in contrast to the guidelines set out by the protocol. (NCI)	
C25746	Reason for Non-Completion	RECOVERY	Recovery	A healing process and/or an outcome implying relative health.  The term is typically used in the context of direct and indirect effects of sickness or injury. (NCI)	
C49628	Reason for Non-Completion	SCREEN FAILURE	Trial Screen Failure	The potential subject who does not meet one or more criteria required for participation in a trial.	
C49632	Reason for Non-Completion	STUDY TERMINATED BY SPONSOR	Study Terminated By Sponsor	An indication that a clinical study was stopped by its sponsor.  (NCI)	
C49633	Reason for Non-Completion	TECHNICAL PROBLEMS	Technical Problem	A problem with some technical aspect of a clinical study, usually related to an instrument.  (NCI)	
C49634	Reason for Non-Completion	WITHDRAWAL BY SUBJECT	Withdrawal by Subject	An indication that a study participant has removed itself from the study.  (NCI)	
C49638	Relation to Reference Period	[STENRF]		The name of a code list that contains terms that reference timepoints within and without a defined time period.	Relation to Reference Period
C49639	Relation to Reference Period	AFTER	Status Post	The time period following a point or another period of time. (NCI)	
C25629	Relation to Reference Period	BEFORE	Prior	Earlier in time or order. (NCI)	
C25490	Relation to Reference Period	DURING	During	At some point in a given period of time. (NCI)	
C49640	Relation to Reference Period	DURING/AFTER	During Or After	Within a certain period of time or after a certain point or period in time. (NCI)	
C17998	Relation to Reference Period	U	Unknown	Not known, not observed, not recorded, or refused. (NCI)	UNKNOWN
C38114	Route of Administration	[ROUTE]		The course by which a substance was administered in order to reach the site of action in the body.	Route of Administration
C38192	Route of Administration	AURICULAR (OTIC)	Auricular Route of Administration	Administration to or by way of the ear.(FDA)	
C38193	Route of Administration	BUCCAL	Buccal Route of Administration	Administration directed toward the cheek, generally from within the mouth.(FDA)	
C38194	Route of Administration	CONJUNCTIVAL	Conjunctival Route of Administration	Administration to the conjunctiva, the delicate membrane that lines the eyelids and covers the exposed surface of the eyeball.(FDA)	
C38675	Route of Administration	CUTANEOUS	Cutaneous Route of Administration	Administration to the skin.(FDA)	
C38197	Route of Administration	DENTAL	Dental Route of Administration	Administration to a tooth or teeth.(FDA)	
C38633	Route of Administration	ELECTRO-OSMOSIS	Electro-osmosis Route of Administration	Administration of through the diffusion of substance through a membrane in an electric field.(FDA)	
C38205	Route of Administration	ENDOCERVICAL	Endocervical Route of Administration	Administration within the canal of the cervix uteri. Synonymous with the term intracervical.(FDA)	
C38206	Route of Administration	ENDOSINUSIAL	Endosinusial Route of Administration	Administration within the nasal sinuses of the head.(FDA)	
C38208	Route of Administration	ENDOTRACHEAL	Endotracheal Route of Administration	Administration directly into the trachea. Synonymous with the term intratracheal.(FDA)	
C38209	Route of Administration	ENTERAL	Enteral Route of Administration	Administration directly into the intestines.(FDA)	
C38210	Route of Administration	EPIDURAL	Epidural Route of Administration	Administration upon or over the dura mater.(FDA)	
C38211	Route of Administration	EXTRA-AMNIOTIC	Extraamniotic Route of Administration	Administration to the outside of the membrane enveloping the fetus.(FDA)	
C38212	Route of Administration	EXTRACORPOREAL	Extracorporeal Circulation Route of Administration	Administration outside of the body.(FDA)	
C38200	Route of Administration	HEMODIALYSIS	Administration Via Hemodialysis	Administration through hemodialysate fluid.(FDA)	
C38215	Route of Administration	INFILTRATION	Infiltration Route of Administration	Administration that results in substances passing into tissue spaces or into cells.(FDA)	
C38219	Route of Administration	INTERSTITIAL	Interstitial Route of Administration	Administration to or in the interstices of a tissue.(FDA)	
C38220	Route of Administration	INTRA-ABDOMINAL	Intraabdominal Route of Administration	Administration within the abdomen.(FDA)	
C38221	Route of Administration	INTRA-AMNIOTIC	Intraamniotic Route of Administration	Administration within the amnion.(FDA)	
C38222	Route of Administration	INTRA-ARTERIAL	Intraarterial Route of Administration	Administration within an artery or arteries.(FDA)	
C38223	Route of Administration	INTRA-ARTICULAR	Intraarticular Route of Administration	Administration within a joint.(FDA)	
C38224	Route of Administration	INTRABILIARY	Intrabiliary Route of Administration	Administration within the bile, bile ducts or gallbladder.(FDA)	
C38225	Route of Administration	INTRABRONCHIAL	Intrabronchial Route of Administration	Administration within a bronchus.(FDA)	
C38226	Route of Administration	INTRABURSAL	Intrabursal Route of Administration	Administration within a bursa.(FDA)	
C38227	Route of Administration	INTRACARDIAC	Intracardiac Route of Administration	Administration within the heart.(FDA)	
C38228	Route of Administration	INTRACARTILAGINOUS	Intracartilaginous Route of Administration	Administration within a cartilage; endochondral.(FDA)	
C38229	Route of Administration	INTRACAUDAL	Intracaudal Route of Administration	Administration within the cauda equina.(FDA)	
C38230	Route of Administration	INTRACAVERNOUS	Intracavernous Route of Administration	Administration within a pathologic cavity, such as occurs in the lung in tuberculosis.(FDA)	
C38231	Route of Administration	INTRACAVITARY	Intracavitary Route of Administration	Administration within a non-pathologic cavity, such as that of the cervix, uterus, or penis, or such as that is formed as the result of a wound.(FDA)	
C38232	Route of Administration	INTRACEREBRAL	Intracerebral Route of Administration	Administration within the cerebrum.(FDA)	
C38233	Route of Administration	INTRACISTERNAL	Intracisternal Route of Administration	Administration within the cisterna magna cerebellomedularis.(FDA)	
C38234	Route of Administration	INTRACORNEAL	Intracorneal Route of Administration	Administration within the cornea (the transparent structure forming the anterior part of the fibrous tunic of the eye).(FDA)	
C38217	Route of Administration	INTRACORONAL, DENTAL	Intracoronal Dental Route of Administration	Administration of a drug within a portion of a tooth which is covered by enamel and which is separated from the roots by a slightly constricted region known as the neck.(FDA)	
C38218	Route of Administration	INTRACORONARY	Intracoronary Route of Administration	Administration within the coronary arteries.(FDA)	
C38235	Route of Administration	INTRACORPORUS CAVERNOSUM	Intracorporus Cavernosum Route of Administration	Administration within the dilatable spaces of the corporus cavernosa of the penis.(FDA)	
C38238	Route of Administration	INTRADERMAL	Intradermal Route of Administration	Administration within the dermis.(FDA)	
C38239	Route of Administration	INTRADISCAL	Intradiscal Route of Administration	Administration within a disc.(FDA)	
C38240	Route of Administration	INTRADUCTAL	Intraductal Route of Administration	Administration within the duct of a gland.(FDA)	
C38241	Route of Administration	INTRADUODENAL	Intraduodenal Route of Administration	Administration within the duodenum.(FDA)	
C38242	Route of Administration	INTRADURAL	Intradural Route of Administration	Administration within or beneath the dura.(FDA)	
C38243	Route of Administration	INTRAEPIDERMAL	Intraepidermal Route of Administration	Administration within the epidermis.(FDA)	
C38245	Route of Administration	INTRAESOPHAGEAL	Intraesophageal Route of Administration	Administration within the esophagus.(FDA)	
C38246	Route of Administration	INTRAGASTRIC	Intragastric Route of Administration	Administration within the stomach.(FDA)	
C38247	Route of Administration	INTRAGINGIVAL	Intragingival Route of Administration	Administration within the gingivae.(FDA)	
C38249	Route of Administration	INTRAILEAL	Intraileal Route of Administration	Administration within the distal portion of the small intestine, from the jejunum to the cecum.(FDA)	
C38250	Route of Administration	INTRALESIONAL	Intralesional Route of Administration	Administration within or introduced directly into a localized lesion.(FDA)	
C38251	Route of Administration	INTRALUMINAL	Intraluminal Route of Administration	Administration within the lumen of a tube.(FDA)	
C38252	Route of Administration	INTRALYMPHATIC	Intralymphatic Route of Administration	Administration within the lymph.(FDA)	
C38253	Route of Administration	INTRAMEDULLARY	Intramedullary Route of Administration	Administration within the marrow cavity of a bone.(FDA)	
C38254	Route of Administration	INTRAMENINGEAL	Intrameningeal Route of Administration	Administration within the meninges (the three membranes that envelope the brain and spinal cord).(FDA)	
C28161	Route of Administration	INTRAMUSCULAR	Intramuscular Route of Administration	Administration within a muscle. (FDA)	
C38255	Route of Administration	INTRAOCULAR	Intraocular Route of Administration	Administration within the eye.(FDA)	
C38256	Route of Administration	INTRAOVARIAN	Intraovarian Route of Administration	Administration within the ovary.(FDA)	
C38257	Route of Administration	INTRAPERICARDIAL	Intrapericardial Route of Administration	Administration within the pericardium.(FDA)	
C38258	Route of Administration	INTRAPERITONEAL	Intraperitoneal Route of Administration	Administration within the peritoneal cavity.(FDA)	
C38259	Route of Administration	INTRAPLEURAL	Intrapleural Route of Administration	Administration within the pleura.(FDA)	
C38260	Route of Administration	INTRAPROSTATIC	Intraprostatic Route of Administration	Administration within the prostate gland.(FDA)	
C38261	Route of Administration	INTRAPULMONARY	Intrapulmonary Route of Administration	Administration within the lungs or its bronchi.(FDA)	
C38262	Route of Administration	INTRASINAL	Intrasinal Route of Administration	Administration within the nasal or periorbital sinuses.(FDA)	
C38263	Route of Administration	INTRASPINAL	Intraspinal Route of Administration	Administration within the vertebral column.(FDA)	
C38264	Route of Administration	INTRASYNOVIAL	Intrasynovial Route of Administration	Administration within the synovial cavity of a joint.(FDA)	
C38265	Route of Administration	INTRATENDINOUS	Intratendinous Route of Administration	Administration within a tendon.(FDA)	
C38266	Route of Administration	INTRATESTICULAR	Intratesticular Route of Administration	Administration within the testicle.(FDA)	
C38267	Route of Administration	INTRATHECAL	Intrathecal Route of Administration	Administration within the cerebrospinal fluid at any level of the cerebrospinal axis, including injection into the cerebral ventricles.(FDA)	
C38207	Route of Administration	INTRATHORACIC	Endothoracic Route of Administration	Administration within the thorax (internal to the ribs); synonymous with the term endothoracic.(FDA)	
C38268	Route of Administration	INTRATUBULAR	Intratubular Route of Administration	Administration within the tubules of an organ.(FDA)	
C38269	Route of Administration	INTRATUMOR	Intratumoral Route of Administration	Administration within a tumor.(FDA)	Intratumor Route of Administration
C38270	Route of Administration	INTRATYMPANIC	Intratympanic Route of Administration	Administration within the auris media.(FDA)	
C38272	Route of Administration	INTRAUTERINE	Intrauterine Route of Administration	Administration within the uterus.(FDA)	
C38273	Route of Administration	INTRAVASCULAR	Intravascular Route of Administration	Administration within a vessel or vessels.(FDA)	
C38276	Route of Administration	INTRAVENOUS	Intravenous Route of Administration	Administration within or into a vein or veins.(FDA)	
C38274	Route of Administration	INTRAVENOUS BOLUS	Intravenous Bolus	Administration within or into a vein or veins all at once.(FDA)	
C38279	Route of Administration	INTRAVENOUS DRIP	Intravenous Drip	Administration within or into a vein or veins over a sustained period of time.(FDA)	
C38277	Route of Administration	INTRAVENTRICULAR	Intraventricular Route of Administration	Administration within a ventricle.(FDA)	
C38278	Route of Administration	INTRAVESICAL	Intravesical Route of Administration	Administration within the bladder.(FDA)	
C38280	Route of Administration	INTRAVITREAL	Intravitreal Route of Administration	Administration within the vitreous body of the eye.(FDA)	
C38203	Route of Administration	IONTOPHORESIS	Iontophoresis Route of Administration	Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body.(FDA)	
C38281	Route of Administration	IRRIGATION	Irrigation-Route of Administration	Administration to bathe or flush open wounds or body cavities.(FDA)	
C38282	Route of Administration	LARYNGEAL	Laryngeal Route of Administration	Administration directly upon the larynx.(FDA)	
C38284	Route of Administration	NASAL	Nasal Route of Administration	Administration to the nose; administered by way of the nose.(FDA)	
C38285	Route of Administration	NASOGASTRIC	Nasogastric Route of Administration	Administration through the nose and into the stomach, usually by means of a tube.(FDA)	
C48623	Route of Administration	NOT APPLICABLE	Route of Administration Not Applicable	Routes of administration are not applicable.(FDA)	
C38286	Route of Administration	OCCLUSIVE DRESSING TECHNIQUE	Occlusive Dressing Technique	Administration by the topical route which is then covered by a dressing which occludes the area.(FDA)	
C38287	Route of Administration	OPHTHALMIC	Ophthalmic Route of Administration	Administration to the external eye.(FDA)	
C38288	Route of Administration	ORAL	Oral Route of Administration	Administration to or by way of the mouth.(FDA)	
C38289	Route of Administration	OROPHARYNGEAL	Oropharyngeal Route of Administration	Administration directly to the mouth and pharynx.(FDA)	
C38290	Route of Administration	OTHER	Other Route of Administration	Administration is different from others on this list.(FDA)	
C38291	Route of Administration	PARENTERAL	Parenteral Route of Administration	Administration by injection, infusion, or implantation.(FDA)	
C38676	Route of Administration	PERCUTANEOUS	Percutaneous Route of Administration	Administration through the skin.(FDA)	
C38292	Route of Administration	PERIARTICULAR	Periarticular Route of Administration	Administration around a joint.(FDA)	
C38677	Route of Administration	PERIDURAL	Peridural Route of Administration	Administration to the outside of the dura mater of the spinal cord.(FDA)	
C38293	Route of Administration	PERINEURAL	Perineural Route of Administration	Administration surrounding a nerve or nerves.(FDA)	
C38294	Route of Administration	PERIODONTAL	Periodontal Route of Administration	Administration around a tooth.(FDA)	
C38295	Route of Administration	RECTAL	Rectal Route of Administration	Administration to the rectum.(FDA)	
C38216	Route of Administration	RESPIRATORY (INHALATION)	Inhalation Route of Administration	Administration within the respiratory tract by inhaling orally or nasally for local or systemic effect.(FDA)	
C38296	Route of Administration	RETROBULBAR	Retrobulbar Route of Administration	Administration behind the pons or behind the eyeball.(FDA)	
C38198	Route of Administration	SOFT TISSUE	Soft Tissue Route Of Administration	Administration into any soft tissue.(FDA)	
C38297	Route of Administration	SUBARACHNOID	Subarachnoid Route of Administration	Administration beneath the arachnoid.(FDA)	
C38298	Route of Administration	SUBCONJUNCTIVAL	Subconjunctival Route of Administration	Administration beneath the conjunctiva.(FDA)	
C38299	Route of Administration	SUBCUTANEOUS	Subcutaneous Route of Administration	Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.(FDA)	
C38300	Route of Administration	SUBLINGUAL	Sublingual Route of Administration	Administration beneath the tongue.(FDA)	
C38301	Route of Administration	SUBMUCOSAL	Submucosal Route of Administration	Administration beneath the mucous membrane.(FDA)	
C38304	Route of Administration	TOPICAL	Topical Route of Administration	Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.(FDA)	
C38305	Route of Administration	TRANSDERMAL	Transdermal Route of Administration	Administration through the dermal layer of the skin to the systemic circulation by diffusion.(FDA)	
C38283	Route of Administration	TRANSMUCOSAL	Mucosal Route of Administration	Administration across the mucosa.(FDA)	
C38307	Route of Administration	TRANSPLACENTAL	Transplacental Route of Administration	Administration through or across the placenta.(FDA)	
C38308	Route of Administration	TRANSTRACHEAL	Transtracheal Route of Administration	Administration through the wall of the trachea.(FDA)	
C38309	Route of Administration	TRANSTYMPANIC	Transtympanic Route of Administration	Administration across or through the tympanic cavity.(FDA)	
C38310	Route of Administration	UNASSIGNED	Unassigned Route of Administration	Route of administration has not yet been assigned.(FDA)	
C38311	Route of Administration	UNKNOWN	Unknown Route of Administration	Route of administration is unknown.(FDA)	
C38312	Route of Administration	URETERAL	Ureteral Route of Administration	Administration into the ureter.(FDA)	
C38271	Route of Administration	URETHRAL	Intraurethral Route of Administration	Administration into the urethra.(FDA)	
C38313	Route of Administration	VAGINAL	Vaginal Route of Administration	Administration into the vagina.(FDA)	
C49705	Severity/Intensity Scale for Adverse Events	[AESEV]		A scale that defines the degree or state of disease existing in a patient as a result of the occurrence of an adverse event. (NCI)	Severity/Intensity of an Adverse Event
C41338	Severity/Intensity Scale for Adverse Events	1	Mild Adverse Event	A type of adverse event that is usually transient and may require only minimal treatment or therapeutic intervention. The event does not generally interfere with usual activities of daily living.	Grade 1; MILD
C41339	Severity/Intensity Scale for Adverse Events	2	Moderate Adverse Event	A type of adverse event that is usually alleviated with additional specific therapeutic intervention. The event interferes with usual activities of daily living, causing discomfort but poses no significant or permanent risk of harm to the research participant.	Grade 2; MODERATE
C41340	Severity/Intensity Scale for Adverse Events	3	Severe Adverse Event	A type of adverse event that requires intensive therapeutic intervention. The event interrupts usual activities of daily living, or significantly affects clinical status. The event possesses a significant risk of harm to the research participant and hospitalization may be required.	Grade 3; SEVERE
C28421	Sex	[SEX]		The assemblage of physical properties or qualities by which male is distinguished from female; the physical difference between male and female; the distinguishing peculiarity of male or female. (NCI)	Sex
C16576	Sex	F	Female	A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)	Female
C20197	Sex	M	Male	A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)	Male
C17998	Sex	U	Unknown	Not known, not observed, not recorded, or refused. (NCI)	UNKNOWN
C45908	Sex	UN	Intersex	A person (one of unisexual specimens) who is born with genitalia and/or secondary sexual characteristics of indeterminate sex, or which combine features of both sexes. (NCI)	Undifferentiated
C49696	Sex of Study Group	[SEXPOP]		 The specific sex, either male, female, or mixed of the subject group being studied. (NCI)	Sex of Participants
C49636	Sex of Study Group	BOTH	Both	One and the other; relating to or being two in conjunction. (NCI)	
C16576	Sex of Study Group	F	Female	A person who belongs to the sex that normally produces ova. The term is used to indicate biological sex distinctions, or cultural gender role distinctions, or both. (NCI)	Female
C20197	Sex of Study Group	M	Male	A person who belongs to the sex that normally produces sperm.  The term is used to indicate biological sex distinctions, cultural gender role distinctions, or both. (NCI)	Male
C25681	Size	[SIZE]	Size	The physical magnitude of something. (NCI)	Size
C49508	Size	LARGE	Large	Of considerable or relatively great size, extent, or capacity. (NCI)	
C49507	Size	MEDIUM	Medium	Mid-way between small and large in number, quantity, magnitude or extent. (NCI)	
C25376	Size	SMALL	Small	Limited in number, quantity, magnitude or extent. (NCI)	
C49558	Submission Domain Abbreviation	[DOMAIN]		A unique, 2-character domain code used in the regulatory submission process.  The domain abbreviation is used consistently throughout the submission, i.e. in the dataset name, as the value of the domain variable within the dataset, and as a prefix for most variable names in the dataset. (CDISC Glossary)	Domain Abbreviation
C49563	Submission Domain Abbreviation	AD	Analysis Dataset Domain	Datasets used for statistical analysis and reporting by the sponsor. These are submitted in addition to the data tabulation datasets.	Analysis Dataset
C49562	Submission Domain Abbreviation	AE	Adverse Event Domain	Adverse events may be captured either as free text or a pre-specified list of terms.	Adverse Events
C49565	Submission Domain Abbreviation	AU	Autopsy Domain	Additional data about deaths, specific to findings from autopsies.	Autopsy
C49566	Submission Domain Abbreviation	BM	Bone Mineral Density Data Domain	Findings resulting from evaluations of bone mineral density.	Bone Mineral Density (BMD) Data
C49567	Submission Domain Abbreviation	BR	Biopsy Domain	Findings resulting from biopsies.	Biopsy
C49568	Submission Domain Abbreviation	CM	Concomitant Medication Domain	Case report form (CRF) data that captures the Concomitant and Prior Medications/Therapies used by the subject. Examples are the Concomitant Medications/Therapies given on an as needed basis and the usual Background Medications/Therapies given for a condition.	Concomitant Meds
C49569	Submission Domain Abbreviation	CO	Comment Domain	The Comments dataset accommodates two sources of comments: 1) those collected alongside other data on topical case report form (CRF) pages such as Adverse Events and 2) those collected on a separate page specifically dedicated to comments.	Comments
C49578	Submission Domain Abbreviation	DA	Drug Accountability Domain	Data regarding the accountability of study drug, such as information on the receipt, dispensing, return, and packaging.	Drug Accountability
C49570	Submission Domain Abbreviation	DC	Disease Characteristics Domain	Data related to the characteristics of a specific disease state under study for a subject.	Disease Characteristics
C49572	Submission Domain Abbreviation	DM	Demographics Domain	The Demographics domain includes a set of essential standard variables that describe each subject in a clinical study.  It is the parent domain for all other observations for human clinical subjects	Demographics
C49576	Submission Domain Abbreviation	DS	Disposition Domain	A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to disposition. (NCI)	Disposition
C49585	Submission Domain Abbreviation	DV	Protocol Deviations Domain	The intent of the domain is to capture protocol violations and deviations during the course of the study and will store only those criteria violation by or deviated from by the subject and not a response to each violation or deviation.	Protocol Deviations
C49625	Submission Domain Abbreviation	EE	Electroencephalogram Domain	Findings resulting from electroencephalogram (EEG) tests.	Electroencephalogram
C49626	Submission Domain Abbreviation	EG	Electrocardiogram Domain	Findings related to the collection of ECG data, including position of the subject, method of evaluation, all cycle measurements and all findings from the ECG including an overall interpretation if collected or derived.	Electrocardiogram
C49587	Submission Domain Abbreviation	EX	Exposure Domain	The Exposure domain model records the details of a subject's exposure to protocol-specified study treatment. Study treatment may be any intervention that is prospectively defined as a test material within a study, and is typically but not always supplied to the subject.	Exposure
C49588	Submission Domain Abbreviation	FH	Family History Domain	A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to family history. (NCI)	Family History
C49589	Submission Domain Abbreviation	HU	Healthcare Resource Utilization Domain	Healthcare resource utilization data such as subject visits to physicians, hospitalizations, and nursing home stays.	Healthcare Resource Utilization
C61536	Submission Domain Abbreviation	IE	Inclusion Exclusion Domain	The intent of the domain model is to only collect those criteria that cause the subject to be in violation of the inclusion/exclusion criteria not a response to each criterion.	Inclusion/Exclusion
C49592	Submission Domain Abbreviation	LB	Laboratory Data Domain	Laboratory test findings including, but is not limited to hematology, clinical chemistry and urinalysis data. This domain does not include microbiology or pharmacokinetic data, which are stored in separate domains.	Laboratory Data
C49602	Submission Domain Abbreviation	MB	Microbiology Specimen Domain	Microbiology specimen findings, including gram stain results, and organisms found.	Microbiology
C49603	Submission Domain Abbreviation	MH	Medical History Domain	The medical history dataset includes the subject's prior history at the start of the trial. Examples of subject medical history information could include general medical history, gynecological history, and primary diagnosis.	Medical History
C49604	Submission Domain Abbreviation	ML	Meal Data Domain	Information regarding the subject's meal consumption, such as fluid intake, amounts, form (solid or liquid state), frequency, etc., typically used for pharmacokinetic analysis.	Meal Data
C61531	Submission Domain Abbreviation	MS	Microbiology Susceptibility Domain	This includes microbiology susceptibility test results, plus results of any other organism-related tests.	Microbiology Susceptibility
C49605	Submission Domain Abbreviation	OM	Organ Measurement Domain	Findings from organ measurement evaluations.	Organ Measurements
C49606	Submission Domain Abbreviation	PC	Pharmacokinetic Concentration Domain	Concentrations of drugs/metabolites in fluids or tissues as a function of time.	Pharmacokinetic Concentration
C49608	Submission Domain Abbreviation	PE	Physical Exam Domain	Findings collected during a physical examination of the subject. It has findings that are discovered that are related to body systems. Does not include vital signs measurements, which are stored in the vital signs domain.	Physical Exam
C61529	Submission Domain Abbreviation	PG	Pharmacogenomics Domain	Pharmacogenomics findings that initially focus on genotype and gene expression data.	Pharmacogenomics
C49607	Submission Domain Abbreviation	PP	Pharmacokinetic Parameters Domain	Pharmacokinetic parameters derived from pharmacokinetic concentration-time (PC) data.	Pharmacokinetic Parameters
C49609	Submission Domain Abbreviation	QS	Questionnaire Domain	Questionnaire data may include, but are not limited to the following: subject reported outcomes, validated or non-validated questionnaires, and validated or non-validated diaries (i.e. data with a common topicality).	Questionnaires
C49610	Submission Domain Abbreviation	SC	Subject Characteristics Domain	The subject characteristics domain is for data not collected in other domains that is subject-related. Examples: subject initials, other race details, eye color, childbearing status, etc.	Subject Characteristics
C49616	Submission Domain Abbreviation	SE	Subject Element Domain	The subject element table describes the actual order of elements followed by the subject, together with the start date/time and end date/time for each element.	Subject Element
C49611	Submission Domain Abbreviation	SG	Surgery Domain	Surgical information.	Surgery
C49612	Submission Domain Abbreviation	SK	Skin Test Domain	Findings from diagnostic skin tests.	Skin Test
C49613	Submission Domain Abbreviation	SL	Sleep Polysomnography Domain	Findings from diagnostic sleep tests (polysomnography).	Sleep Polysomnography Data
C49614	Submission Domain Abbreviation	ST	Stress Exercise Test Data Domain	Findings from exercise stress tests.	Stress (Exercise) Test Data
C49615	Submission Domain Abbreviation	SU	Substance Use Domain	The intent of the domain is to capture substance use information that may be used to assess the efficacy and/or safety of therapies that look to mitigate the effects of chronic substance use.	Substance Use
C49617	Submission Domain Abbreviation	SV	Subject Visits Domain	The subject visits table describes the actual start and end data/time for each visit of each individual subject.	Subject Visits
C49618	Submission Domain Abbreviation	TA	Trial Arms Domain	The trial arms table describes each planned arm in the trial. An arm is described as an ordered sequence of elements.	Trial Arms
C49619	Submission Domain Abbreviation	TE	Trial Elements Domain	The trial elements table describes the element code that is unique for each element, the element description, and the rules for starting and ending an element.	Trial Elements
C49620	Submission Domain Abbreviation	TI	Trial Inclusion and Exclusion Criteria Domain	The trial summary information domain is not subject oriented. It contains one record for each of the inclusion and exclusion criteria for the trial.	Trial Inclusion/Exclusion Criteria
C53483	Submission Domain Abbreviation	TS	Trial Summary Domain	The trial summary information domain is not subject oriented. It contains one record for each trial summary characteristic.	Trial Summary
C49621	Submission Domain Abbreviation	TV	Trial Visits Domain	The trial visits table describes the planned order and number of visits in the study within each arm.	Trial Visits
C49622	Submission Domain Abbreviation	VS	Vital Signs Domain	Measurements including but not limited to blood pressure, temperature, respiration, body surface area, BMI, height and weight.	Vital Signs
C49658	Trial Blinding Schema	[TBLIND]		The name of a code list that contains terms to define the type of blinding for the trial. (NCI)	Trial Blinding Schema
C15228	Trial Blinding Schema	DOUBLE BLIND	Double Blind Study	A study in which neither the subject nor the investigator nor the research team interacting with the subject or data during the trial knows what treatment a subject is receiving. (CDISC glossary)	
C49659	Trial Blinding Schema	OPEN LABEL	Open Label Study	A trial in which subjects and investigators know which product each subject is receiving; opposite of a blinded or double-blind study. (CDISC glossary)	
C28233	Trial Blinding Schema	SINGLE BLIND	Single Blind Study	 A study in which one party, either the investigator or the subject, does not know which medication or placebo is administered to the subject; also called singlemasked study. (CDISC glossary)	
C49654	Trial Indication Type	CURE	Cure Study	A type of study protocol designed to evaluate intervention(s) aimed to cure a disease or condition.  (NCI)	
C49653	Trial Indication Type	DIAGNOSIS	Diagnosis Study	A type of study protocol designed to evaluate intervention(s) aimed at identifying a disease or condition.  (NCI)	
C49655	Trial Indication Type	MITIGATION	Adverse Effect Mitigation Study	A type of study designed to identify actions necessary to eliminate or reduce the risk to human life or well-being as a result of a particular medication or treatment regimen.  (NCI)	
C49657	Trial Indication Type	PREVENTION	Prevention Study	A type of study designed to identify actions necessary to permanently eliminate or reduce the long-term risk to human life as a result of a particular medication or treatment regimen.	
C49652	Trial Indication Type	TINDTP		The name of a code list that contains terms to define the type of trial, e.g. cure or prevention. (NCI)	Trial Indication Type
C49656	Trial Indication Type	TREATMENT	Treatment Study	A type of study protocol designed to evaluate intervention(s) for treatment of disease, syndrome or condition.	
C48281	Trial Phase	[TPHASE]		 Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)	Trial Phase
C15600	Trial Phase	1	Phase I Trial	The initial introduction of an investigational new drug into humans. Phase 1 studies are typically closely monitored and may be conducted in patients or normal volunteer subjects. NOTE: These studies are designed to determine the metabolism and pharmacologic actions of the drug in humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. During Phase 1, sufficient information about the drug’s pharmacokinetics and pharmacological effects should be obtained to permit the design of well-controlled, scientifically valid, Phase 2 studies. The total number of subjects and patients included in Phase I studies varies with the drug, but is generally in the range of 20 to 80. Phase 1 studies also include studies of drug metabolism, structure-activity relationships, and mechanism of action in humans, as well as studies in which investigational drugs are used as research tools to explore biological phenomena or disease processes.  [After FDA CDER Handbook, ICH E8] (CDISC glossary)	Trial Phase 1
C15693	Trial Phase	1-2	Phase I/II Trial	A class of clinical study that combines elements characteristic of traditional Phase I and Phase II trials. See also Phase I, Phase II.	Trial Phase 1-2
C15601	Trial Phase	2	Phase II Trial	Phase 2. Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. NOTE: Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)	Trial Phase 2
C15694	Trial Phase	2-3	Phase II/III Trial	A class of clinical study that combines elements characteristic of traditional Phase II and Phase III trials.	Trial Phase 2-3
C49686	Trial Phase	2A	Phase II A Trial	A clinical research protocol generally refered to as a pilot or feasibility trial that aims to prove the concept of the new intervention in question. (NCI)	Trial Phase 2A
C49688	Trial Phase	2B	Phase II B Trial	A clinical research protocol generally refered to as a well-controlled and pivotal trial that aims to prove the mechanism of action of the new intervention in question. A pivotal study will generally be well-controlled, randomized, of adequate size, and whenever possible, double-blind. (NCI)	Trial Phase 2B
C15602	Trial Phase	3	Phase III Trial	Phase 3. Studies are expanded controlled and uncontrolled trials. They are performed after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather the additional information about effectiveness and safety that is needed to confirm efficacy and evaluate the overall benefit–risk relationship of the drug and to provide an adequate basis for physician labeling. NOTE: Phase 3 studies usually include from several hundred to several thousand subjects. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)	Trial Phase 3
C49687	Trial Phase	3A	Phase IIIA Trial	A classification typically assigned retrospectively to a Phase III trial upon determination by regulatory authorities of a need for a Phase III B trial.	Trial Phase 3A
C49689	Trial Phase	3B	Phase III B Trial	A subcategory of Phase III trials done near the time of approval to elicit additional findings. NOTE: Dossier review may continue while associated Phase IIIB trials are conducted. These trials may be required as a condition of regulatory authority approval.	Trial Phase 3B
C15603	Trial Phase	4	Phase IV Trial	Phase 4. Postmarketing (Phase 4) studies to delineate additional information about the drug’s risks, benefits, and optimal use that may be requested by regulatory authorities in conjunction with marketing approval. NOTE: These studies could include, but would not be limited to, studying different doses or schedules of administration than were used in Phase 2 studies, use of the drug in other patient populations or other stages of the disease, or use of the drug over a longer period of time. [After FDA CDER Handbook, ICH E8]  (CDISC glossary)	Trial Phase 4
C47865	Trial Phase	5	Phase V Trial	Postmarketing surveillance is sometimes referred to as Phase V.	Trial Phase 5
C48660	Trial Phase	NA	Not Applicable	Determination of a value is not relevant in the current context. (NCI)	NOT APPLICABLE
C49691	Trial Summary Parameter	[TSPARM]		Individual characteristics of a clinical trial, e.g. description of trial design, trial blinding schema, and primary objective of trial. (NCI)	Trial Summary Parameter
C49703	Trial Summary Parameter	ADDON	Test Product Added to Existing Treatment	The addition of a therapeutic product to the existing regimen in a clinical trial, where both entities remain as discrete products.	Added on to Existing Treatments
C49700	Trial Summary Parameter	AEDICT	Adverse Event Dictionary	A reference source that provides meanings of words related to adverse events. (NCI)	Adverse Event Dictionary
C49694	Trial Summary Parameter	AGEMAX	Planned Maximum Age of Subjects	The anticipated maximum age of the subjects to be entered in a clinical trial. (NCI)	Planned Maximum Age of Subjects
C49693	Trial Summary Parameter	AGEMIN	Planned Minimum Age of Subjects	The anticipated minimum age of the subjects to be entered in a clinical trial. (NCI)	Planned Minimum Age of Subjects
C20587	Trial Summary Parameter	AGESPAN	Age Group	Subgroups of populations based on age. (NCI)	Age Span
C50400	Trial Summary Parameter	AGEU	Age Unit	Those units of time that are routinely used to express the age of a person. (NCI)	Age Units
C25488	Trial Summary Parameter	DOSE	Dose	The amount of drug administered to a patient or test subject at one time or the total quantity administered. [AMA Manual of Style] (CDISC Glossary)	Dose per Administration
C49701	Trial Summary Parameter	DRUGDICT	Drug Dictionary	A reference source that provides meanings of words related to drugs. (NCI)	Drug Dictionary
C49697	Trial Summary Parameter	LENGTH	Trial Length	The anticipated length of a clinical trial measured as a unit of time. (NCI)	Length of Trial
C49702	Trial Summary Parameter	MHDICT	Medical History Dictionary	A reference source that provides meanings of words related to medical history. (NCI)	Medical History Dictionary
C49692	Trial Summary Parameter	PLANSUB	Planned Subject Number	The number of subjects entered in a clinical trial. (NCI)	Planned Number of Subjects
C25196	Trial Summary Parameter	RANDOM	Randomization	The process of assigning trial subjects to treatment or control groups using an element of chance to determine the assignments in order to reduce bias. NOTE: Unequal randomization is used to allocate subjects into groups at a differential rate; for example, three subjects may be assigned to a treatment group for every one assigned to the control group. [ICH E6 1.48] See also balanced study. (CDISC glossary)	Trial is Randomized
C38114	Trial Summary Parameter	ROUTE	Route of Administration	The course by which a substance was administered in order to reach the site of action in the body.	Route of Administration
C49696	Trial Summary Parameter	SEXPOP	Sex of Study Group	The specific sex, either male, female, or mixed of the subject group being studied. (NCI)	Sex of Participants
C49698	Trial Summary Parameter	STOPRULE	Study Stop Rules	The rule, regulation and/or condition that determines the point in time when a clinical trial will be terminated. (NCI)	Stopping Rules for the Study
C49658	Trial Summary Parameter	TBLIND	Trial Blinding Schema	The name of a code list that contains terms to define the type of blinding for the trial. (NCI)	Trial Blinding Schema
C49647	Trial Summary Parameter	TCNTRL	Control Type	Comparator against which the study treatment is evaluated (e.g., concurrent (placebo, no treatment, dose-response, active), external (historical, published literature).	Type of Control
C49650	Trial Summary Parameter	TDIGRP	Diagnosis Group	A grouping of individuals on the basis of a shared procedure or disease, or lack thereof (e.g. healthy volunteers, type 2 diabetic subjects, subjects with renal cell cancer).  Standardized naming systems are available that define the groups within which a subject should be placed. (NCI)	Diagnosis Group
C49652	Trial Summary Parameter	TINDTP	Trial Indication Type	The name of a code list that contains terms to define the type of trial, e.g. cure or prevention.  (NCI)	Trial Indication Type
C49802	Trial Summary Parameter	TITLE	Trial Title	The name of a clinical trial. (NCI)	Trial Title
C48281	Trial Summary Parameter	TPHASE	Trial Phase	Clinical trials are broken into three or four phases: Phase I tests a new drug or treatment for safety in a small group; Phase II expands the study to a larger group of people; Phase III expands the study to an even larger group of people to measure whether the treatment actually benefits patients, and whether its benefits exceed its risks; and Phase IV takes place after the drug or treatment has been licensed and marketed. (NCI)	Trial Phase
C49660	Trial Summary Parameter	TTYPE	Trial Type	The type of clinical trial performed e.g. efficacy, safety. (NCI)	Type of Trial
C49660	Trial Type	[TTYPE]		The type of clinical trial performed e.g. efficacy, safety. (NCI)	Type of Trial
C49664	Trial Type	BIO-AVAILABILITY	Bioavailability Study	A study of the degree to which or rate at which a drug or other substance is absorbed or becomes available at the site of physiological activity after administration. (NCI)	
C49665	Trial Type	BIO-EQUIVALENCE	Therapeutic Equivalency Study	A study most often used to compare the efficacy of different formulations to treat a given disease.  It is the testing of an old versus a new formulation in healthy volunteers or subjects with the disease under study and usually in one dose. (NCI)	
C49666	Trial Type	EFFICACY	Efficacy Study	A study of the relative therapeutic efficacy of treatment of a disease. Usually this is a Phase II or III study. (NCI)	
C49662	Trial Type	PHARMACODYNAMIC	Pharmacodynamic Study	A study of the biochemical and physiological effect of a drug and the mechanism of drug action and the relationship between drug concentration and effect. (NCI)	
C39493	Trial Type	PHARMACOECONOMIC	Pharmacoeconomic Study	A study that assesses the value associated with a given drug in therapeutic and economic terms. This type of study is multidisciplinary in nature and takes into consideration the social and economic costs (resource utilization costs including direct, indirect, and intangible costs) of drug therapy in addition to its direct therapeutic benefits. Analyses relate the difference in therapeutic benefits to the difference in costs between treatment alternatives. (NCI)	
C49661	Trial Type	PHARMACOGENOMIC	Pharmacogenomic Study	A study of identification and analysis of genomic variations that affect the efficacy of a drug. Pharmacogenomic studies can potentially be predictive of an individual's drug-response or adverse reactions or susceptibility to iatrogenic disorders, and may also reveal new targets that can help in the design of new drugs. (NCI)	
C49663	Trial Type	PHARMACOKINETIC	Pharmacokinetic Study	A study of the process by which a drug is absorbed, distributed, metabolized, and eliminated by the body. (NCI)	
C49667	Trial Type	SAFETY	Safety Study	A study of the relative safety of treatment of a disease. Usually this is a Phase I or II trial. (NCI)	
C49675	Units for Vital Signs Results	[VSRESU]		The unit used to record and describe the result of a test investigating a vital sign. (NCI)	Units for Vital Signs Results
C25613	Units for Vital Signs Results	%	Percentage	A fraction or ratio with 100 understood as the denominator. (NCI)	Percentage
C49673	Units for Vital Signs Results	BEATS/MIN	Beats per Minute	The number of heartbeats measured per minute time. (NCI)	Beats per Minute
C49674	Units for Vital Signs Results	BREATHS/MIN	Breaths per Minute	The number of breaths (inhalation and exhalation) taken per minute time. (NCI)	Breaths per Minute
C42559	Units for Vital Signs Results	C	Degree Celsius	A unit of temperature of the temperature scale designed so that the freezing point of water is 0 degrees and the boiling point is 100 degrees at standard atmospheric pressure. The current official definition of the Celsius sets 0.01 C to be at the triple point of water and a degree to be 1/273.16 of the difference in temperature between the triple point of water and absolute zero. One degree Celsius represents the same temperature difference as one Kelvin. (NCI)	Degree Celsius
C49668	Units for Vital Signs Results	cm	Centimeter	A basic unit of length in the former CGS version of metric system, equal to one hundredth of a meter or approximately 0.393 700 787 inch. (NCI)	Centimeter
C44277	Units for Vital Signs Results	F	Degree Fahrenheit	The Fahrenheit temperature scale is named after the German physicist Gabriel Fahrenheit (1686-1736), who proposed it in 1724.  In this scale, the freezing point of water is 32 degrees Fahrenheit and the boiling point is 212 degrees, placing the boiling and melting points of water 180 degrees apart. In this scale a degree Fahrenheit is 5/9ths of a kelvin (or of a degree Celsius), and minus 40 degrees Fahrenheit is equal to minus 40 degrees Celsius. (NCI)	Degree Fahrenheit
C48155	Units for Vital Signs Results	g	Gram	A metric unit of mass equal to one one thousandth of a kilogram. (NCI)	Gram
C48500	Units for Vital Signs Results	IN	Inch	A traditional unit of length equal to 2.54 centimeters. (NCI)	Inch
C28252	Units for Vital Signs Results	kg	Kilogram	The basic SI unit of mass.  It is defined as the mass of an international prototype in the form of a platinum-iridium cylinder kept at Sevres in France. It is the only basic unit still defined in terms of a material object, and also the only one with a prefix [kilo] already in place. A kilogram is equal to 1,000 grams and 2.204 622 6 pounds. (NCI)	Kilogram
C49671	Units for Vital Signs Results	kg/m2	Kilogram Per Square Meter	The SI derived unit of spread rate of a substance by mass, used also as a measure of area density. (NCI)	Kilogram Per Square Meter
C48531	Units for Vital Signs Results	LB	Pound	A traditional unit of mass. By international agreement, one avoirdupois pound is equal to exactly 0.453 592 37 kilogram, 16 ounces, or 1.215 28 troy pounds. (NCI)	Pound
C42569	Units for Vital Signs Results	m2	Square Meter	The SI unit of area measurement equal to a square whose sides are one meter long. Square meter is equal to 10,000 square centimeters; 0.01 ares; 1.196 square yards; 10.76 square feet; 1550 square inches. (NCI)	Square Meter
C49670	Units for Vital Signs Results	mmHG	Millimeter of Mercury	A unit of pressure equal to 0.001316 atmosphere and equal to the pressure indicated by one millimeter rise of mercury in a barometer at the Earth's surface. (NCI)	Millimeter of Mercury
C42554	Units for Vital Signs Results	ohm	Ohm	A unit of electrical resistance equal to the resistance between two points on a conductor when a potential difference of one volt between them produces a current of one ampere. Ohm is also used to measure impedance and reactance for complex resistance. A measurement in ohms is the reciprocal of a measurement in siemens. (NCI)	
C49672	Vital Signs	[VSTEST]		The name given to the test that analyzes a particular set of vital signs including temperature, respiratory rate, heart beat (pulse), and blood pressure. (NCI)	Vital Signs Test Name
C16358	Vital Signs	BMI	Body Mass Index	A general indicator of the body fat an individual is carrying based upon the ratio of weight to height. (NCI)	Body Mass Index
C12472	Vital Signs	BODYFAT	Adipose Tissue	A specialized form of connective tissue consisting primarily of adipocytes (fat cells), surrounded by a meshwork of collagen fibers.	Body Fat
C25157	Vital Signs	BSA	Body Surface Area	A measure of the 2-dimensional extent of the body surface (i.e., the skin).  Body surface area (BSA) can be calculated by mathematical formula or from a chart that relates height to weight.  BSA is often an important factor in dosing. (NCI)	Body Surface Area
C25299	Vital Signs	DIABP	Diastolic Blood Pressure	The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. (NCI)	Diastolic Blood Pressure
C49680	Vital Signs	FRMSIZE	Body Frame Size	The categorization of a person's body frame into small, medium and large based on the measurement of wrist circumference or the breadth of the elbow. (NCI)	Frame Size
C25347	Vital Signs	HEIGHT	Height	The vertical measurement or distance from the base to the top of an object; the vertical dimension of extension. (NCI)	Height
C49677	Vital Signs	HR	Heart Rate	The number of heartbeats per unit of time, usually expressed as beats per minute. (NCI)	Heart Rate
C49679	Vital Signs	MAP	Mean Arterial Pressure	The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. (NCI)	Mean Arterial Pressure
C49676	Vital Signs	PULSE	Pulse Rate	The rate of the pulse as observed in an artery, expressed as beats per minute. It can be measured at several anatomical sites, including the wrist, neck, temple, groin, behind the knees, or on top of the foot. (NCI)	Pulse Rate
C49678	Vital Signs	RESP	Respiratory Rate	The rate of breathing (inhalation and exhalation) measured within in a unit time, usually expressed as breaths per minute. (NCI)	Respiratory Rate
C25298	Vital Signs	SYSBP	Systolic Blood Pressure	The blood pressure during the contraction of the left ventricle of the heart.	Systolic Blood Pressure
C25206	Vital Signs	TEMP	Temperature	The property of a body or region of space that determines whether or not there will be a net flow of heat into it or out of it from a neighboring body or region and in which direction (if any) the heat will flow, perceptible by living organism as a somatic sensation of cold or heat. It is a measure of the average translational kinetic energy associated with the disordered microscopic motion of atoms and molecules. Temperature is measured in one of the three standard temperature scales: Celsius, Kelvin, and Fahrenheit. (NCI)	Temperature
C25208	Vital Signs	WEIGHT	Weight	The vertical force exerted by a mass as a result of gravity. (NCI)	Weight
C49486	Yes, No, Unknown, or Not Applicable Response	[NY]		A term that is used to indicate a question with permissible values of yes/no/unknown/not applicable.	No Yes Response
C49487	Yes, No, Unknown, or Not Applicable Response	N	No	The non-affirmative response to a question. (NCI)	No
C48660	Yes, No, Unknown, or Not Applicable Response	NA	Not Applicable	Determination of a value is not relevant in the current context. (NCI)	NOT APPLICABLE
C17998	Yes, No, Unknown, or Not Applicable Response	U	Unknown	Not known, not observed, not recorded, or refused. (NCI)	UNKNOWN
C49488	Yes, No, Unknown, or Not Applicable Response	Y	Yes	The affirmative response to a question. (NCI)	Yes